AI in Private Practice: 2025 Adoption Trends & Statistics PDF Free Download
1 / 17/17
100%
AI
i
n
P
r
i
v
a
t
e
P
r
ac
t
ice
:
2025
A
d
opt
i
on
T
r
e
n
d
s
&
S
t
a
t
i
st
ic
s
B
y
A
d
r
ie
n
L
a
ur
e
nt
,
CEO
a
t
I
ntu
i
t
i
on
L
ab
s
•
11/25/2025
•
35
m
i
n
r
ead
hea
lt
hca
r
e
ai ai
i
n
pr
i
v
a
t
e
pr
ac
t
ice
m
edica
l
pr
ac
t
ice
t
ech
nolo
g
y p
h
ys
icia
n
b
urnout
c
l
i
n
ica
l
d
o
c
um
e
nt
a
t
i
on
a
m
bie
nt
s
c
r
ibe ge
n
e
r
a
t
i
v
e
ai
i
n
hea
lt
hca
r
e eh
r
i
nt
eg
r
a
t
i
on m
edica
l
ai
st
a
t
i
st
ic
s
IntuitionLabs - Custom AI Software Development
from the leading AI expert Adrien Laurent AI in Private Practice: 2025 Adoption Trends & Statistics
© 2025 IntuitionLabs.ai - North America's Leading AI Software Development Firm for Pharmaceutical & Biotech. All rights reserved. Page 1 of 17
E
x
ec
ut
i
v
e
S
umm
a
ry
B
y
l
a
t
e
2025,
AI
t
ech
nolo
gie
s
a
r
e
bec
om
i
n
g
c
ommonpl
ace
tools
i
n
pr
i
v
a
t
e
m
edica
l
pr
ac
t
ice
s
,
e
sp
ecia
lly
f
or
o
ff
lo
adi
n
g
rout
i
n
e
ad
m
i
n
i
str
a
t
i
v
e
t
a
s
k
s
.
F
or
e
x
a
mpl
e
,
surv
e
ys
i
n
dica
t
e
t
ha
t
rou
gh
ly
on
e
-
ha
l
f
o
f
a
m
b
ul
a
tory
pr
ac
t
ice
s
r
e
port
us
i
n
g
a
t
l
ea
st
on
e
AI
tool
i
n
dai
ly
op
e
r
a
t
i
ons
(
[1]
www
.
m
edica
l
ec
onom
ic
s
.
c
om
)
(
[2]
www
.
a
m
a
-
a
ssn
.
or
g
).
T
he
s
e
tools
pr
i
m
a
r
i
ly
t
a
r
ge
t
p
a
p
e
rwor
k
:
AI
m
edica
l
s
c
r
ibe
s
,
a
utom
a
t
ed
fa
x
/
d
o
c
um
e
nt
pro
ce
ss
i
n
g
,
a
n
d
s
ched
ul
i
n
g
/
cha
t
b
ots
de
l
i
v
e
r
t
he
l
a
r
ge
st
t
i
m
e
s
a
v
i
n
g
s
.
I
n
on
e
r
ece
nt
surv
e
y
,
72
%
o
f
AI
-
us
i
n
g
pr
ac
t
ice
s
r
e
l
ied
on
a
n
a
m
bie
nt
s
c
r
ibe
(
e
.
g
.
S
uno
h
.
ai
)
f
or
c
l
i
n
ica
l
d
o
c
um
e
nt
a
t
i
on
,
w
i
t
h
two
-
t
hi
r
d
s
o
f
t
h
os
e
us
e
rs
s
a
v
i
n
g
1–4
h
ours
or
mor
e
p
e
r
da
y
on
p
a
p
e
rwor
k
(
[3]
www
.
m
edica
l
ec
onom
ic
s
.
c
om
).
S
i
m
i
l
a
rly
,
64
%
o
f
AI
ad
opt
e
rs
r
e
port
ed
s
a
v
i
n
g
a
t
l
ea
st
on
e
h
our
dai
ly
b
y
a
utom
a
t
i
n
g
fa
x
a
n
d
f
orm
m
a
n
age
m
e
nt
t
a
s
k
s
(
[4]
www
.
m
edica
l
ec
onom
ic
s
.
c
om
).
A
d
m
i
n
i
str
a
t
i
v
e
a
utom
a
t
i
on
,
i
n
fac
t
,
i
s
s
ee
n
a
s
t
he
l
eadi
n
g
AI
a
ppl
ica
t
i
on
:
57
%
o
f
U
.
S
.
p
h
ys
icia
ns
i
n
2024
ide
nt
ified
“
add
r
e
ss
i
n
g
ad
m
i
n
i
str
a
t
i
v
e
b
ur
de
n
t
h
rou
gh
a
utom
a
t
i
on
”
a
s
t
he
top
opportun
i
ty
f
or
AI
(
[2]
www
.
a
m
a
-
a
ssn
.
or
g
).
T
he
s
e
efficie
n
c
y
gai
ns
a
r
e
sor
e
ly
n
eeded
:
i
n
2025,
c
l
i
n
icia
ns
e
st
i
m
a
t
e
sp
e
n
di
n
g
2–3
h
ours
on
ad
m
i
n
f
or
e
v
e
ry
h
our
o
f
p
a
t
ie
nt
ca
r
e
(
[5]
www
.
e
mp
a
t
hia
.
ai
).
D
e
sp
i
t
e
g
row
i
n
g
e
nt
h
us
ia
sm
,
ad
opt
i
on
r
e
m
ai
ns
un
e
v
e
n
.
P
h
ys
icia
ns
i
n
l
a
r
ge
or
syst
e
m
-
affi
l
ia
t
ed
or
ga
n
i
z
a
t
i
ons
ha
v
e
fa
r
mor
e
acce
ss
to
ad
v
a
n
ced
AI
t
ha
n
t
h
os
e
i
n
sm
a
ll
i
n
de
p
e
n
de
nt
pr
ac
t
ice
s
.
I
n
on
e
AMA
r
e
port
,
n
ea
rly
40
%
o
f
h
osp
i
t
a
l
-
ba
s
ed
p
h
ys
icia
ns
had
acce
ss
to
AI
-
a
ss
i
st
ed
diag
nost
ic
s
or
wor
kf
low
tools
,
v
e
rsus
only
~10
%
o
f
d
o
c
tors
i
n
solo
or
sm
a
ll
-
g
roup
pr
ac
t
ice
(
[6]
www
.
h
n
a
-
n
e
t
.
c
om
).
L
ike
w
i
s
e
,
72
%
o
f
e
mploy
ed
p
h
ys
icia
ns
r
e
port
ed
us
i
n
g
AI
tools
,
c
omp
a
r
ed
to
64
%
o
f
t
h
os
e
i
n
pr
i
v
a
t
e
pr
ac
t
ice
(
[7]
www
.
a
m
a
-
a
ssn
.
or
g
).
S
m
a
ll
e
r
pr
ac
t
ice
s
o
f
t
e
n
ci
t
e
c
ost
,
l
ack
o
f
t
ech
n
ica
l
support
,
a
n
d
i
mpl
e
m
e
nt
a
t
i
on
h
ur
d
l
e
s
a
s
ba
rr
ie
rs
(
[8]
www
.
a
m
a
-
a
ssn
.
or
g
)
(
[9]
www
.
h
n
a
-
n
e
t
.
c
om
).
C
on
ce
rns
ov
e
r
da
t
a
pr
i
v
ac
y
,
a
l
g
or
i
t
h
m
tr
a
nsp
a
r
e
n
c
y
,
a
n
d
l
iabi
l
i
ty
a
lso
t
e
mp
e
r
ad
opt
i
on
i
n
pr
i
v
a
t
e
s
e
tt
i
n
g
s
(
[10]
www
.
a
m
a
-
a
ssn
.
or
g
)
(
[11]
www
.
h
n
a
-
n
e
t
.
c
om
).
O
v
e
r
a
ll
,
h
ow
e
v
e
r
,
d
o
c
tors
ʼ
a
tt
i
tu
de
s
a
r
e
s
hif
t
i
n
g
pos
i
t
i
v
e
ly
:
two
-
t
hi
r
d
s
o
f
surv
e
y
ed
p
h
ys
icia
ns
r
e
port
us
i
n
g
AI
i
n
som
e
f
orm
(
up
f
rom
38
%
i
n
2023),
a
n
d
68–79
%
s
ee
c
l
ea
r
ad
v
a
nt
age
s
to
t
he
s
e
tools
(
[2]
www
.
a
m
a
-
a
ssn
.
or
g
)
(
[12]
www
.
ic
t
hea
lt
h
.
or
g
).
L
oo
ki
n
g
ahead
,
AI
i
s
e
xp
ec
t
ed
to
dee
p
e
n
i
ts
rol
e
i
n
pr
i
v
a
t
e
pr
ac
t
ice
s
.
M
aj
or
EHR
v
e
n
d
ors
a
r
e
e
m
beddi
n
g
AI
f
un
c
t
i
ons
i
nto
t
hei
r
pl
a
t
f
orms
(
f
or
e
x
a
mpl
e
,
A
t
he
n
ahea
lt
h
ʼ
s
“
AI
-
n
a
t
i
v
e
”
EHR
,
roll
ed
out
i
n
2025,
prov
ide
s
s
ea
ml
e
ss
AI
-
d
r
i
v
e
n
d
o
c
um
e
nt
a
t
i
on
,
r
e
v
e
nu
e
-
c
y
c
l
e
,
a
n
d
p
a
t
ie
nt
-
e
n
gage
m
e
nt
fea
tur
e
s
ac
ross
160,000+
prov
ide
r
e
n
d
po
i
nts
(
[13]
www
.
fie
r
cehea
lt
hca
r
e
.
c
om
)).
G
e
n
e
r
a
t
i
v
e
AI
mo
de
ls
(
e
.
g
.
l
a
r
ge
l
a
n
g
u
age
mo
de
ls
)
a
r
e
begi
nn
i
n
g
to
a
ss
i
st
w
i
t
h
t
a
s
k
s
l
ike
summ
a
r
i
z
i
n
g
p
a
t
ie
nt
da
t
a
,
d
r
af
t
i
n
g
c
l
i
n
ica
l
not
e
s
,
a
n
d
a
nsw
e
r
i
n
g
p
a
t
ie
nt
qu
e
r
ie
s
,
a
n
d
most
hea
lt
hca
r
e
l
eade
rs
(75–92
%
)
be
l
ie
v
e
ge
n
e
r
a
t
i
v
e
AI
w
i
ll
tr
a
ns
f
orm
efficie
n
c
y
a
n
d
deci
s
i
on
-
m
aki
n
g
(
[14]
www
.
de
lo
i
tt
e
.
c
om
).
I
f
c
urr
e
nt
tr
e
n
d
s
c
ont
i
nu
e
,
pr
i
v
a
t
e
pr
ac
t
ice
s
t
ha
t
effec
t
i
v
e
ly
i
nt
eg
r
a
t
e
AI
st
a
n
d
to
achie
v
e
su
b
st
a
nt
ia
l
c
ost
a
n
d
t
i
m
e
s
a
v
i
n
g
s
,
be
tt
e
r
p
a
t
ie
nt
e
xp
e
r
ie
n
ce
,
a
n
d
r
e
l
ief
o
f
c
l
i
n
icia
n
b
urnout
.
H
ow
e
v
e
r
,
c
los
i
n
g
t
he
“
digi
t
a
l
di
v
ide
”
–
e
nsur
i
n
g
sm
a
ll
a
n
d
rur
a
l
pr
ac
t
ice
s
ha
v
e
t
he
support
,
aff
or
dab
l
e
t
ech
nolo
g
y
,
a
n
d
tr
ai
n
i
n
g
to
ad
opt
AI
–
w
i
ll
be
c
r
i
t
ica
l
.
W
i
t
h
out
ca
r
ef
ul
pol
ic
y
a
n
d
v
e
n
d
or
support
,
di
sp
a
r
i
t
ie
s
m
a
y
g
row
:
e
xp
e
rts
w
a
rn
t
ha
t
un
checked
,
AI
c
oul
d
bec
om
e
a
be
n
efi
t
e
n
j
oy
ed
m
ai
nly
b
y
l
a
r
ge
,
w
e
ll
-
f
un
ded
syst
e
ms
(
[15]
www
.
h
n
a
-
n
e
t
.
c
om
)
(
[16]
www
.
m
edica
l
ec
onom
ic
s
.
c
om
).
T
ab
l
e
1.
K
e
y
AI A
d
opt
i
on
M
e
tr
ic
s
i
n
H
eal
t
hca
r
e
(2023–2025
surv
e
ys
)
Y
ea
r
S
our
ce
(
P
opul
a
t
i
on
)
K
e
y
F
i
n
di
n
g
2024
MGMA S
t
a
t
P
oll
(
[17]
www
.
m
g
m
a
.
c
om
)
(422
m
edica
l
g
roups
)
43
%
o
f
m
edica
l
g
roup
r
e
spon
de
nts
r
e
port
ed
addi
n
g
or
e
xp
a
n
di
n
g
AI
tools
i
n
2024
(
vs
.
21
%
i
n
2023).
2024
AMA S
urv
e
y
(
[2]
www
.
a
m
a
-
a
ssn
.
or
g
)
(
p
h
ys
icia
ns
)
66
%
o
f
U
.
S
.
p
h
ys
icia
ns
r
e
port
ed
us
i
n
g
AI
i
n
t
hei
r
pr
ac
t
ice
(
up
f
rom
38
%
i
n
2023);
68
%
s
a
w
som
e
ad
v
a
nt
age
to
AI
.
2025
AMA A
n
a
lys
i
s
(
[7]
www
.
a
m
a
-
a
ssn
.
or
g
)
(
p
h
ys
icia
ns
)
AI
us
e
r
e
port
ed
b
y
72
%
o
f
e
mploy
ed
d
o
c
tors
vs
.
64
%
o
f
pr
i
v
a
t
e
-
pr
ac
t
ice
d
o
c
tors
.
IntuitionLabs - Custom AI Software Development
from the leading AI expert Adrien Laurent AI in Private Practice: 2025 Adoption Trends & Statistics
© 2025 IntuitionLabs.ai - North America's Leading AI Software Development Firm for Pharmaceutical & Biotech. All rights reserved. Page 2 of 17
Y
ea
r
S
our
ce
(
P
opul
a
t
i
on
)
K
e
y
F
i
n
di
n
g
2025
e
C
l
i
n
ica
l
W
or
k
s
/
M
edica
l
E
c
onom
ic
s
(
[1]
www
.
m
edica
l
ec
onom
ic
s
.
c
om
)
(887
pr
ac
t
ice
s
a
t
c
on
fe
r
e
n
ce
)
50
%
o
f
a
m
b
ul
a
tory
ca
r
e
pr
ac
t
ice
s
r
e
port
ed
us
i
n
g
a
t
l
ea
st
on
e
AI
tool
.
2025
M
on
e
yp
e
nny
S
urv
e
y
(
[18]
www
.
m
edica
l
ec
onom
ic
s
.
c
om
)
(
U
.
S
.
hea
lt
hca
r
e
or
g
s
)
66
%
o
f
hea
lt
hca
r
e
or
ga
n
i
z
a
t
i
ons
a
r
e
us
i
n
g
or
ac
t
i
v
e
ly
c
ons
ide
r
i
n
g
AI
i
n
op
e
r
a
t
i
ons
.
2025
P
hi
l
i
ps
FHI G
lo
ba
l
R
e
port
(
[19]
www
.
ic
t
hea
lt
h
.
or
g
)
(
[20]
www
.
ic
t
hea
lt
h
.
or
g
)
84
%
o
f
c
l
i
n
icia
ns
be
l
ie
v
e
AI
ca
n
a
utom
a
t
e
r
e
p
e
t
i
t
i
v
e
t
a
s
k
s
;
79
%
o
f
d
o
c
tors
vs
.
59
%
o
f
p
a
t
ie
nts
e
xp
ec
t
AI
to
i
mprov
e
out
c
om
e
s
.
2025
U
K GP S
urv
e
y
(
D
igi
t
H
ea
lt
h
)
(
[21]
pm
c
.
n
cbi
.
nlm
.
n
ih
.
g
ov
)
25
%
o
f
surv
e
y
ed
U
K
ge
n
e
r
a
l
pr
ac
t
i
t
i
on
e
rs
r
e
port
ed
us
i
n
g
ge
n
e
r
a
t
i
v
e
AI
tools
i
n
c
l
i
n
ica
l
pr
ac
t
ice
.
2024/25
D
e
lo
i
tt
e
LSHC S
urv
e
y
(
[14]
www
.
de
lo
i
tt
e
.
c
om
)
(
hea
lt
hca
r
e
l
eade
rs
)
75
%
o
f
l
eadi
n
g
hea
lt
hca
r
e
c
omp
a
n
ie
s
e
xp
e
r
i
m
e
nt
w
i
t
h
or
pl
a
n
to
s
ca
l
e
ge
n
e
r
a
t
i
v
e
AI
;
92
%
e
xp
ec
t
efficie
n
c
y
gai
ns
w
i
t
h
AI
.
I
ntro
d
u
c
t
i
on
a
n
d
B
ackg
roun
d
A
rt
ificia
l
i
nt
e
ll
ige
n
ce
(
AI
)
–
b
ro
ad
ly
defi
n
ed
a
s
a
l
g
or
i
t
h
ms
t
ha
t
l
ea
rn
f
rom
da
t
a
to
support
t
a
s
k
s
–
i
s
r
a
p
id
ly
r
e
s
ha
p
i
n
g
hea
lt
hca
r
e
de
l
i
v
e
ry
.
I
n
i
t
ia
lly
p
i
on
ee
r
ed
i
n
r
e
s
ea
r
ch
s
e
tt
i
n
g
s
,
AI
i
s
now
fi
n
di
n
g
pr
ac
t
ica
l
a
ppl
ica
t
i
ons
i
n
m
edica
l
pr
ac
t
ice
.
I
n
h
osp
i
t
a
ls
a
n
d
e
xp
e
rts
ʼ
Q
u
a
t
e
rn
i
ons
,
AI
ha
s
de
monstr
a
t
ed
be
n
efi
ts
i
n
i
m
agi
n
g
i
nt
e
rpr
e
t
a
t
i
on
,
pr
edic
t
i
v
e
a
n
a
lyt
ic
s
,
a
n
d
wor
kf
low
opt
i
m
i
z
a
t
i
on
(
[22]
i
ntu
i
t
i
onl
ab
s
.
ai
)
(
[23]
n
e
wsroom
.
c
l
e
v
e
l
a
n
dc
l
i
n
ic
.
or
g
).
O
v
e
r
t
he
p
a
st
decade
,
pr
i
v
a
t
e
pr
ac
t
ice
s
a
n
d
a
m
b
ul
a
tory
c
l
i
n
ic
s
(
outp
a
t
ie
nt
pr
i
m
a
ry
ca
r
e
a
n
d
sp
ecia
lty
o
ffice
s
)
ha
v
e
g
r
ad
u
a
lly
ad
opt
ed
digi
t
a
l
tools
(
e
.
g
.
EHR
s
),
s
e
tt
i
n
g
t
he
st
age
f
or
pr
ac
t
ica
l
AI
i
nt
eg
r
a
t
i
on
.
T
he
CO
V
ID
-19
p
a
n
de
m
ic
f
urt
he
r
acce
l
e
r
a
t
ed
digi
t
a
l
hea
lt
h
a
n
d
t
e
l
e
m
edici
n
e
ad
opt
i
on
,
m
aki
n
g
prov
ide
rs
a
n
d
p
a
t
ie
nts
mor
e
c
om
f
ort
ab
l
e
w
i
t
h
r
e
mot
e
a
n
d
t
ech
nolo
g
y
-
d
r
i
v
e
n
ca
r
e
.
P
r
i
v
a
t
e
pr
ac
t
ice
s
face
ac
ut
e
pr
e
ssur
e
s
t
ha
t
m
ake
AI
a
pp
ea
l
i
n
g
.
T
he
U
.
S
.
ha
s
a
w
e
ll
-
d
o
c
um
e
nt
ed
p
h
ys
icia
n
s
h
ort
age
(
e
st
.
15,000–48,000
s
h
ort
b
y
2034
(
[24]
www
.
e
mp
a
t
hia
.
ai
)),
g
row
i
n
g
p
a
t
ie
nt
lo
ad
s
,
a
n
d
r
i
s
i
n
g
ad
m
i
n
i
str
a
t
i
v
e
b
ur
de
ns
.
P
h
ys
icia
ns
o
f
t
e
n
r
e
port
sp
e
n
di
n
g
2–3
h
ours
on
p
a
p
e
rwor
k
f
or
each
h
our
o
f
di
r
ec
t
p
a
t
ie
nt
ca
r
e
(
[5]
www
.
e
mp
a
t
hia
.
ai
).
B
ur
de
ns
i
n
c
lu
de
not
e
-
wr
i
t
i
n
g
,
c
o
di
n
g
,
bi
ll
i
n
g
,
i
nsur
a
n
ce
a
ut
h
or
i
z
a
t
i
ons
,
a
n
d
m
a
n
agi
n
g
p
a
t
ie
nt
c
ommun
ica
t
i
ons
.
T
he
s
e
i
n
efficie
n
cie
s
c
ontr
ib
ut
e
to
b
urnout
a
n
d
r
ed
u
ced
ca
p
aci
ty
f
or
p
a
t
ie
nt
ca
r
e
.
AI
prom
i
s
e
s
to
a
ll
e
v
ia
t
e
m
a
ny
o
f
t
he
s
e
t
a
s
k
s
:
b
y
a
utom
a
t
i
n
g
rout
i
n
e
ch
or
e
s
,
c
l
i
n
icia
ns
ca
n
pot
e
nt
ia
lly
de
vot
e
mor
e
t
i
m
e
to
p
a
t
ie
nts
(
[2]
www
.
a
m
a
-
a
ssn
.
or
g
)
(
[19]
www
.
ic
t
hea
lt
h
.
or
g
).
A
s
on
e
e
xp
e
rt
o
b
s
e
rv
e
s
,
“
AI
-
e
xpos
e
t
a
s
k
s
”
su
ch
a
s
ad
m
i
n
i
str
a
t
i
v
e
wor
kf
lows
a
r
e
r
i
p
e
f
or
a
utom
a
t
i
on
,
e
n
ab
l
i
n
g
d
o
c
tors
to
f
o
c
us
on
c
ompl
e
x
c
l
i
n
ica
l
deci
s
i
ons
(
[25]
www
.
a
m
a
-
a
ssn
.
or
g
).
W
i
t
h
t
hi
s
c
ont
e
xt
,
t
he
p
a
st
fe
w
y
ea
rs
ha
v
e
s
ee
n
a
prol
ife
r
a
t
i
on
o
f
AI
solut
i
ons
f
or
c
l
i
n
ic
s
:
c
lou
d
-
ba
s
ed
vo
ice
s
c
r
ibe
s
(
e
.
g
.
A
b
r
idge
,
S
u
ki
,
A
m
bie
nt
C
l
i
n
ica
l
I
nt
e
ll
ige
n
ce
),
cha
t
b
ot
s
ched
ul
e
rs
,
a
utom
a
t
ed
pr
i
or
-
a
ut
h
or
i
z
a
t
i
on
pl
a
t
f
orms
,
pr
edic
t
i
v
e
tr
iage
tools
,
a
n
d
mor
e
.
EHR
v
e
n
d
ors
(
E
p
ic
,
A
t
he
n
ahea
lt
h
,
C
e
rn
e
r
/
O
r
ac
l
e
)
a
r
e
e
m
beddi
n
g
AI
mo
d
ul
e
s
f
or
c
o
di
n
g
,
d
o
c
um
e
nt
a
t
i
on
,
a
n
d
a
l
e
rts
.
T
ech
nolo
g
y
ad
v
a
n
ce
s
(
l
a
r
ge
r
da
t
a
s
e
ts
,
be
tt
e
r
mo
de
ls
)
a
n
d
c
onsum
e
r
-
faci
n
g
AI
(
e
.
g
.
C
ha
t
GP
T
)
ha
v
e
r
ai
s
ed
e
xp
ec
t
a
t
i
ons
f
or
w
ha
t
t
he
s
e
tools
ca
n
d
o
.
A
t
t
he
s
a
m
e
t
i
m
e
,
pu
b
l
ic
a
w
a
r
e
n
e
ss
o
f
da
t
a
pr
i
v
ac
y
(
HIPAA
)
a
n
d
ca
lls
f
or
e
t
hica
l
AI
ha
v
e
g
rown
.
T
he
n
e
t
r
e
sult
i
s
a
high
ly
d
yn
a
m
ic
l
a
n
d
s
ca
p
e
w
he
r
e
i
nnov
a
t
i
ons
e
m
e
r
ge
r
a
p
id
ly
.
T
hi
s
r
e
port
surv
e
ys
t
he
c
urr
e
nt
st
a
t
e
o
f
AI
ad
opt
i
on
i
n
pr
i
v
a
t
e
m
edica
l
pr
ac
t
ice
s
(
a
s
o
f
D
ece
m
be
r
2025),
e
x
a
m
i
n
i
n
g
h
ow
dee
ply
AI
ha
s
p
e
n
e
tr
a
t
ed
non
-
h
osp
i
t
a
l
ca
r
e
,
w
ha
t
fac
tors
i
n
f
lu
e
n
ce
upt
ake
,
a
n
d
w
ha
t
i
mp
ac
ts
—
b
ot
h
r
ea
l
i
z
ed
a
n
d
pot
e
nt
ia
l
—
a
r
e
e
m
e
r
gi
n
g
.
W
e
d
r
a
w
on
mult
i
pl
e
p
e
rsp
ec
t
i
v
e
s
:
r
ece
nt
surv
e
ys
o
f
p
h
ys
icia
ns
a
n
d
pr
ac
t
ice
s
,
ca
s
e
e
x
a
mpl
e
s
,
e
xp
e
rt
a
n
a
lys
e
s
,
a
n
d
pu
b
l
i
s
hed
da
t
a
.
T
he
r
e
port
c
ov
e
rs
(1)
hi
stor
ica
l
de
v
e
lopm
e
nts
o
f
c
l
i
n
ica
l
AI
,
(2)
c
urr
e
nt
ad
opt
i
on
r
a
t
e
s
a
n
d
us
e
ca
s
e
s
i
n
pr
i
v
a
t
e
pr
ac
t
ice
s
,
(3)
ke
y
be
n
efi
ts
a
n
d
cha
ll
e
n
ge
s
o
b
s
e
rv
ed
,
(4)
st
akeh
ol
de
r
v
ie
wpo
i
nts
(
c
l
i
n
icia
ns
,
IntuitionLabs - Custom AI Software Development
from the leading AI expert Adrien Laurent AI in Private Practice: 2025 Adoption Trends & Statistics
© 2025 IntuitionLabs.ai - North America's Leading AI Software Development Firm for Pharmaceutical & Biotech. All rights reserved. Page 3 of 17
p
a
t
ie
nts
,
ad
m
i
n
i
str
a
tors
,
r
eg
ul
a
tors
),
(5)
sp
ecific
ca
s
e
stu
die
s
,
a
n
d
(6)
f
utur
e
i
mpl
ica
t
i
ons
a
n
d
r
ec
omm
e
n
da
t
i
ons
.
A
ll
c
l
ai
ms
be
low
a
r
e
support
ed
b
y
da
t
a
f
rom
r
e
put
ab
l
e
sour
ce
s
a
n
d
p
ee
r
-
r
e
v
ie
w
ed
stu
die
s
.
H
i
stor
ica
l
C
ont
e
xt
o
f
AI
i
n
M
edici
n
e
AI
i
n
m
edici
n
e
tr
ace
s
back
decade
s
(
e
.
g
.
e
xp
e
rt
syst
e
ms
i
n
t
he
1970
s
),
b
ut
ad
opt
i
on
w
a
s
slow
outs
ide
l
ab
or
a
tor
ie
s
.
I
n
r
ece
nt
hi
story
,
two
m
aj
or
w
a
v
e
s
e
n
ab
l
ed
c
urr
e
nt
de
v
e
lopm
e
nts
.
F
i
rst
,
t
he
w
ide
spr
ead
digi
t
i
z
a
t
i
on
o
f
hea
lt
hca
r
e
(
EHR
ad
opt
i
on
acce
l
e
r
a
t
ed
b
y
M
ea
n
i
n
gf
ul
U
s
e
i
n
ce
nt
i
v
e
s
i
n
t
he
2010
s
)
c
r
ea
t
ed
l
a
r
ge
e
l
ec
tron
ic
da
t
a
s
e
ts
a
n
d
digi
t
a
l
wor
kf
lows
r
i
p
e
f
or
AI
e
n
ha
n
ce
m
e
nt
.
S
ec
on
d
,
t
he
r
i
s
e
o
f
m
achi
n
e
l
ea
rn
i
n
g
a
n
d
dee
p
l
ea
rn
i
n
g
(
ci
r
ca
2010
s
)
d
r
a
m
a
t
ica
lly
i
mprov
ed
AI
ʼ
s
ca
p
abi
l
i
t
ie
s
(
e
.
g
.
i
m
age
r
ec
o
g
n
i
t
i
on
).
T
he
s
e
tr
e
n
d
s
c
onv
e
r
ged
so
t
ha
t
b
y
t
he
ea
rly
2020
s
,
h
osp
i
t
a
ls
a
n
d
acade
m
ic
ce
nt
e
rs
w
e
r
e
p
i
lot
i
n
g
or
de
ploy
i
n
g
AI
f
or
r
adi
olo
g
y
i
m
agi
n
g
a
n
a
lys
i
s
,
p
a
t
h
olo
g
y
sl
ide
r
e
v
ie
w
,
a
n
d
s
e
ps
i
s
a
l
e
rts
(
[23]
n
e
wsroom
.
c
l
e
v
e
l
a
n
dc
l
i
n
ic
.
or
g
)
(
[26]
n
e
wsroom
.
c
l
e
v
e
l
a
n
dc
l
i
n
ic
.
or
g
).
F
or
e
x
a
mpl
e
,
c
onvolut
i
on
a
l
n
e
ur
a
l
n
e
ts
tr
ai
n
ed
on
v
a
st
i
m
agi
n
g
a
r
chi
v
e
s
now
a
ss
i
st
i
n
diag
nos
i
n
g
diabe
t
ic
r
e
t
i
nop
a
t
h
y
a
n
d
lun
g
no
d
ul
e
s
.
C
l
i
n
ica
l
deci
s
i
on
support
syst
e
ms
us
e
pr
edic
t
i
v
e
mo
de
ls
to
f
l
ag
high
-
r
i
s
k
p
a
t
ie
nts
.
M
ea
nw
hi
l
e
,
ad
m
i
n
i
str
a
t
i
v
e
AI
tools
—
l
ike
rul
e
s
e
n
gi
n
e
s
f
or
c
o
di
n
g
or
n
a
tur
a
l
-
l
a
n
g
u
age
vo
ice
r
ec
o
g
n
i
t
i
on
—
bega
n
to
i
mprov
e
efficie
n
c
y
.
H
ow
e
v
e
r
,
pr
i
v
a
t
e
pr
ac
t
ice
s
(
e
sp
ecia
lly
sm
a
ll
on
e
s
)
l
agged
i
n
i
t
ia
lly
:
t
he
y
o
f
t
e
n
l
acked
t
he
I
T
i
n
f
r
a
stru
c
tur
e
a
n
d
ca
p
i
t
a
l
f
or
ad
v
a
n
ced
p
i
lots
.
H
i
stor
ica
lly
,
only
l
a
r
ge
h
osp
i
t
a
ls
or
i
nt
eg
r
a
t
ed
g
roups
de
ploy
ed
c
l
i
n
ica
l
AI
a
t
s
ca
l
e
.
I
n
de
p
e
n
de
nt
pr
ac
t
ice
s
l
a
r
ge
ly
f
o
c
us
ed
on
c
onv
e
rt
i
n
g
to
EHR
s
a
n
d
add
r
e
ss
i
n
g
ba
s
ic
digi
t
a
l
n
eed
s
.
B
y
2020–2022,
t
he
s
e
ba
rr
ie
rs
bega
n
to
e
ro
de
.
C
lou
d
-
ba
s
ed
AI
s
e
rv
ice
s
a
n
d
l
igh
t
e
r
-
w
eigh
t
S
aa
S
tools
e
m
e
r
ged
t
ha
t
did
not
r
e
qu
i
r
e
e
xt
e
ns
i
v
e
lo
ca
l
i
n
f
r
a
stru
c
tur
e
.
T
e
l
ehea
lt
h
pl
a
t
f
orms
(
ad
opt
ed
w
ide
ly
d
ur
i
n
g
t
he
CO
V
ID
-19
p
a
n
de
m
ic
)
i
ntro
d
u
ced
d
o
c
tors
a
n
d
p
a
t
ie
nts
to
n
e
w
AI
-
d
r
i
v
e
n
i
nt
e
r
face
s
(
f
or
e
x
a
mpl
e
,
cha
t
b
ots
f
or
tr
iage
a
n
d
p
a
t
ie
nt
port
a
ls
).
C
on
c
urr
e
ntly
,
vo
ice
a
ss
i
st
a
nts
beca
m
e
pow
e
r
f
ul
:
A
m
bie
nt
C
l
i
n
ica
l
I
nt
e
ll
ige
n
ce
(
AI
s
c
r
ibi
n
g
)
s
e
rv
ice
s
l
a
un
ched
,
i
n
w
hich
a
n
AI
l
i
st
e
ns
to
d
o
c
tor
-
p
a
t
ie
nt
c
onv
e
rs
a
t
i
ons
a
n
d
ge
n
e
r
a
t
e
s
v
i
s
i
t
not
e
s
.
S
u
ch
i
nnov
a
t
i
ons
prom
i
s
ed
to
c
ut
d
o
c
um
e
nt
a
t
i
on
t
i
m
e
d
r
a
m
a
t
ica
lly
.
P
r
e
l
i
m
i
n
a
ry
stu
die
s
s
h
ow
ed
prom
i
s
i
n
g
efficie
n
c
y
gai
ns
:
hea
lt
h
syst
e
ms
s
a
w
d
o
c
um
e
nt
a
t
i
on
AI
“
p
a
y
o
ff
wor
k
h
ours
”
(
[3]
www
.
m
edica
l
ec
onom
ic
s
.
c
om
)
(
[27]
acade
m
ic
.
oup
.
c
om
).
I
n
l
egi
sl
a
t
i
v
e
a
n
d
pol
ic
y
a
r
e
n
a
s
,
a
w
a
r
e
n
e
ss
o
f
hea
lt
hca
r
e
AI
a
lso
ros
e
.
R
eg
ul
a
tors
(
e
.
g
.
FDA
)
bega
n
c
l
ea
r
i
n
g
AI
-
e
n
ab
l
ed
m
edica
l
de
v
ice
s
(
ov
e
r
1000
b
y
2025
(
[16]
www
.
m
edica
l
ec
onom
ic
s
.
c
om
)).
T
he
AMA
a
n
d
ot
he
r
pro
fe
ss
i
on
a
l
b
o
die
s
i
ssu
ed
w
hi
t
e
p
a
p
e
rs
a
n
d
pr
i
n
ci
pl
e
s
on
AI
e
t
hic
s
a
n
d
s
afe
ty
.
P
a
t
ie
nts
a
n
d
c
l
i
n
icia
ns
st
a
rt
ed
deba
t
i
n
g
w
he
n
AI
s
h
oul
d
be
t
he
“
st
a
n
da
r
d
o
f
ca
r
e
.”
B
y
m
id
-2020
s
,
t
he
s
ce
n
e
w
a
s
s
e
t
:
AI
w
a
s
no
lon
ge
r
f
r
i
n
ge
,
a
n
d
pr
i
v
a
t
e
c
l
i
n
ic
l
eade
rs
w
e
r
e
i
n
c
r
ea
s
i
n
g
ly
a
w
a
r
e
o
f
i
t
a
s
a
tool
.
C
urr
e
nt
S
t
a
t
e
o
f
AI A
d
opt
i
on
i
n
P
r
i
v
a
t
e
P
r
ac
t
ice
s
O
v
e
r
a
ll
A
d
opt
i
on
R
a
t
e
s
a
n
d
T
r
e
n
d
s
R
ece
nt
surv
e
ys
i
n
dica
t
e
t
ha
t
AI
ad
opt
i
on
i
n
a
m
b
ul
a
tory
pr
ac
t
ice
s
i
s
acce
l
e
r
a
t
i
n
g
.
A
l
a
t
e
-2025
stu
d
y
o
f
n
ea
rly
900
p
a
rt
ici
p
a
nts
ac
ross
U
.
S
.
c
l
i
n
ic
s
f
oun
d
t
ha
t
ha
l
f
o
f
pr
ac
t
ice
s
w
e
r
e
a
lr
ead
y
us
i
n
g
a
t
l
ea
st
on
e
AI
tool
(
[1]
www
.
m
edica
l
ec
onom
ic
s
.
c
om
).
I
n
CMS
t
e
rms
,
“
pr
ac
t
ice
s
”
i
n
c
lu
de
sm
a
ll
d
o
c
tors
ʼ
o
ffice
s
up
to
m
id
-
s
i
z
ed
g
roups
;
t
hi
s
su
gge
sts
AI
i
s
mov
i
n
g
f
rom
l
a
r
ge
i
nst
i
tut
i
ons
i
nto
c
ommun
i
ty
m
edici
n
e
.
A
n
AMA
p
h
ys
icia
n
surv
e
y
(
N
ov
2024)
s
i
m
i
l
a
rly
f
oun
d
66
%
o
f
d
o
c
tors
r
e
port
ed
us
i
n
g
som
e
f
orm
o
f
AI
i
n
pr
ac
t
ice
(
up
f
rom
38
%
i
n
2023)
(
[2]
www
.
a
m
a
-
a
ssn
.
or
g
).
A
not
he
r
AMA
qu
e
ry
(
M
a
y
2025)
high
l
igh
t
ed
a
ga
p
b
y
pr
ac
t
ice
typ
e
:
ab
out
72
%
o
f
h
osp
i
t
a
l
-
e
mploy
ed
p
h
ys
icia
ns
r
e
port
ed
AI
us
e
,
v
e
rsus
64
%
o
f
pr
i
v
a
t
e
-
pr
ac
t
ice
p
h
ys
icia
ns
(
[7]
www
.
a
m
a
-
a
ssn
.
or
g
).
T
he
s
e
fig
ur
e
s
c
ontr
a
st
s
ha
rply
w
i
t
h
ea
rl
ie
r
y
ea
rs
;
f
or
e
x
a
mpl
e
,
a
2024
MGMA
poll
s
h
ow
ed
only
21
%
o
f
m
edica
l
IntuitionLabs - Custom AI Software Development
from the leading AI expert Adrien Laurent AI in Private Practice: 2025 Adoption Trends & Statistics
© 2025 IntuitionLabs.ai - North America's Leading AI Software Development Firm for Pharmaceutical & Biotech. All rights reserved. Page 4 of 17
g
roups
had
e
xp
a
n
ded
AI
us
age
i
n
2023,
r
i
s
i
n
g
to
43
%
b
y
2024
(
[17]
www
.
m
g
m
a
.
c
om
).
I
n
s
h
ort
,
AI
ad
opt
i
on
ha
s
rou
gh
ly
d
ou
b
l
ed
each
y
ea
r
i
n
m
a
ny
polls
o
f
U
.
S
.
hea
lt
hca
r
e
(
T
ab
l
e
1).
T
hi
s
g
rowt
h
i
s
l
a
r
ge
ly
d
r
i
v
e
n
b
y
wor
kf
lows
t
ha
t
de
m
a
n
d
efficie
n
c
y
.
S
urv
e
y
r
e
spon
de
nts
c
ons
i
st
e
ntly
ci
t
e
ad
m
i
n
i
str
a
t
i
v
e
efficie
n
c
y
a
s
t
he
pr
i
m
a
ry
r
ea
son
to
ad
opt
AI
.
I
n
2024,
57
%
o
f
p
h
ys
icia
ns
ide
nt
ified
“
add
r
e
ss
i
n
g
ad
m
i
n
i
str
a
t
i
v
e
b
ur
de
n
”
a
s
t
he
top
AI
opportun
i
ty
(
[2]
www
.
a
m
a
-
a
ssn
.
or
g
).
B
y
c
ontr
a
st
,
pur
e
c
l
i
n
ica
l
diag
nost
ic
a
ss
i
st
tools
r
e
m
ai
n
a
m
i
nor
i
ty
o
f
AI
us
e
i
n
pr
i
v
a
t
e
c
l
i
n
ic
s
.
N
on
e
t
he
l
e
ss
,
som
e
pr
ac
t
ice
s
(
e
sp
ecia
lly
l
a
r
ge
r
mult
i
sp
ecia
lty
g
roups
)
ha
v
e
beg
un
i
mpl
e
m
e
nt
i
n
g
AI
i
n
c
l
i
n
ica
l
rol
e
s
(
e
.
g
.
r
adi
olo
g
y
tr
iage
,
de
rm
a
tolo
g
y
i
m
age
a
n
a
lys
i
s
).
A
cc
or
di
n
g
to
a
2024
surv
e
y
o
f
U
.
S
.
hea
lt
h
syst
e
ms
(
h
osp
i
t
a
ls
/
l
a
r
ge
pr
ac
t
ice
s
),
all
r
e
spon
de
nt
or
ga
n
i
z
a
t
i
ons
had
ad
opt
ed
a
t
l
ea
st
a
m
bie
nt
c
l
i
n
ica
l
d
o
c
um
e
nt
a
t
i
on
AI
,
w
he
r
ea
s
only
“
m
a
ny
”
had
i
m
agi
n
g
/
r
i
s
k
tools
(
[28]
acade
m
ic
.
oup
.
c
om
).
T
hi
s
su
gge
sts
t
ha
t
w
hi
l
e
sm
a
ll
-
pr
ac
t
ice
ad
opt
i
on
o
f
tru
e
diag
nost
ic
AI
i
s
st
i
ll
e
m
e
r
gi
n
g
,
no
-
pr
ac
t
ice
a
r
ea
ha
s
bee
n
untou
ched
b
y
AI
(
T
ab
l
e
2).
T
he
tr
e
n
d
i
s
g
lo
ba
l
.
A
U
K
surv
e
y
(
J
a
n
2025)
f
oun
d
25
%
o
f
ge
n
e
r
a
l
pr
ac
t
i
t
i
on
e
rs
us
i
n
g
ge
n
e
r
a
t
i
v
e
AI
f
or
t
a
s
k
s
l
ike
d
o
c
um
e
nt
a
t
i
on
a
n
d
diffe
r
e
nt
ia
l
diag
nos
i
s
(
[21]
pm
c
.
n
cbi
.
nlm
.
n
ih
.
g
ov
).
I
n
I
t
a
ly
ʼ
s
L
om
ba
r
d
y
r
egi
on
,
a
2024–2025
stu
d
y
o
f
pu
b
l
ic
a
n
d
pr
i
v
a
t
e
prov
ide
rs
r
e
port
ed
t
ha
t
43
%
had
de
ploy
ed
som
e
AI
a
ppl
ica
t
i
ons
(
mostly
CE
-
m
a
r
ked
i
m
agi
n
g
tools
),
w
hi
l
e
57
%
had
not
ad
opt
ed
a
ny
AI
(
[29]
pm
c
.
n
cbi
.
nlm
.
n
ih
.
g
ov
).
S
i
m
i
l
a
rly
,
a
n
i
nt
e
rn
a
t
i
on
a
l
surv
e
y
b
y
P
hi
l
i
ps
r
e
port
ed
t
ha
t
84
%
o
f
hea
lt
hca
r
e
wor
ke
rs
be
l
ie
v
e
AI
ca
n
a
utom
a
t
e
r
e
p
e
t
i
t
i
v
e
t
a
s
k
s
,
a
n
d
t
ha
t
79
%
o
f
d
o
c
tors
e
xp
ec
t
AI
to
i
mprov
e
p
a
t
ie
nt
out
c
om
e
s
(
[19]
www
.
ic
t
hea
lt
h
.
or
g
)
(
[12]
www
.
ic
t
hea
lt
h
.
or
g
)
(
t
h
ou
gh
only
59
%
o
f
p
a
t
ie
nts
s
ha
r
ed
t
ha
t
opt
i
m
i
sm
).
I
n
A
s
ia
-
P
acific
a
n
d
ot
he
r
m
a
r
ke
ts
,
i
n
d
ustry
r
e
ports
pro
jec
t
ro
b
ust
g
rowt
h
(
o
f
t
e
n
>30
%
a
nnu
a
l
g
rowt
h
)
i
n
hea
lt
hca
r
e
AI
sp
e
n
di
n
g
t
h
rou
gh
2030,
i
n
dica
t
i
n
g
g
lo
ba
l
mom
e
ntum
.
I
n
T
ab
l
e
1
ab
ov
e
,
w
e
summ
a
r
i
z
e
mult
i
pl
e
r
ece
nt
stu
die
s
.
T
he
c
ons
i
st
e
n
c
y
i
s
not
ab
l
e
:
a
roun
d
two
-
t
hi
r
d
s
o
f
d
o
c
tors
or
or
ga
n
i
z
a
t
i
ons
r
e
port
som
e
e
n
gage
m
e
nt
w
i
t
h
AI
,
a
n
d
t
hi
s
i
s
r
i
s
i
n
g
r
a
p
id
ly
y
ea
r
-
to
-
y
ea
r
.
C
ru
cia
lly
,
h
ow
e
v
e
r
,
e
n
gageme
nt
r
a
n
ge
s
f
rom
p
i
lot
/
c
ons
ide
r
a
t
i
on
to
pro
d
u
c
t
i
on
de
ploym
e
nt
.
M
a
ny
pr
ac
t
ice
s
m
a
y
be
“
e
xplor
i
n
g
”
a
t
ech
b
ut
not
y
e
t
f
ully
i
nt
eg
r
a
t
ed
w
i
t
h
wor
kf
lows
.
B
ut
t
he
ba
s
e
l
i
n
e
–
a
m
aj
or
i
ty
ha
v
i
n
g
a
t
l
ea
st
on
e
AI
pro
jec
t
–
i
s
unpr
ecede
nt
ed
f
or
w
i
ll
-
be
e
r
a
.
K
e
y
AI A
ppl
ica
t
i
ons
i
n
P
r
i
v
a
t
e
P
r
ac
t
ice
s
P
r
i
v
a
t
e
pr
ac
t
ice
s
to
da
y
a
pply
AI
pr
i
m
a
r
i
ly
to
wor
kf
low
a
n
d
ad
m
i
n
i
str
a
t
i
v
e
t
a
s
k
s
,
w
i
t
h
s
ec
on
da
ry
us
e
i
n
c
l
i
n
ica
l
support
a
n
d
p
a
t
ie
nt
e
n
gage
m
e
nt
.
T
ab
l
e
2
high
l
igh
ts
m
aj
or
a
ppl
ica
t
i
on
a
r
ea
s
.
S
om
e
i
llustr
a
t
i
v
e
e
x
a
mpl
e
s
:
C
l
i
n
ica
l
D
o
c
um
e
nt
a
t
i
on
(
A
m
bie
nt
S
c
r
ibi
n
g
).
AI
-
pow
e
r
ed
s
c
r
ibe
s
l
i
st
e
n
to
t
he
d
o
c
tor
-
p
a
t
ie
nt
c
onv
e
rs
a
t
i
on
a
n
d
ge
n
e
r
a
t
e
stru
c
tur
ed
v
i
s
i
t
not
e
s
.
S
uno
h
.
ai
,
A
b
r
idge
,
S
u
ki
,
a
n
d
E
p
ic
ʼ
s
a
m
bie
nt
not
e
s
(
P
ow
e
r
ed
b
y
N
u
a
n
ce
)
a
r
e
e
x
a
mpl
e
s
.
I
n
t
he
surv
e
y
o
f
AI
-
us
i
n
g
pr
ac
t
ice
s
,
72
%
r
e
port
ed
r
e
ly
i
n
g
on
S
uno
h
.
ai
f
or
not
e
-
t
aki
n
g
(
[3]
www
.
m
edica
l
ec
onom
ic
s
.
c
om
).
T
wo
-
t
hi
r
d
s
o
f
t
h
os
e
us
e
rs
s
a
v
ed
1–4+
h
ours
p
e
r
da
y
.
A
n
AMA
surv
e
y
s
i
m
i
l
a
rly
f
oun
d
~22
%
o
f
pr
i
v
a
t
e
p
h
ys
icia
ns
us
i
n
g
AI
f
or
d
o
c
um
e
nt
a
t
i
on
or
c
o
di
n
g
(
p
h
ys
icia
ns
i
n
e
mploy
ed
s
e
tt
i
n
g
s
r
e
port
ed
21
%
)
(
[30]
www
.
a
m
a
-
a
ssn
.
or
g
).
M
ost
ad
opt
e
rs
s
a
y
t
he
t
i
m
e
s
a
v
ed
i
s
t
he
g
r
ea
t
e
st
i
mm
edia
t
e
be
n
efi
t
.
A
m
bie
nt
AI
a
llows
c
l
i
n
icia
ns
to
a
vo
id
t
edi
ous
tr
a
ns
c
r
i
pt
i
on
af
t
e
r
each
v
i
s
i
t
,
pot
e
nt
ia
lly
i
mprov
i
n
g
t
h
orou
gh
n
e
ss
a
n
d
r
ed
u
ci
n
g
b
urnout
.
F
a
x
a
n
d
D
o
c
um
e
nt
M
a
n
age
m
e
nt
.
M
a
ny
U
.
S
.
c
l
i
n
ic
s
st
i
ll
r
ecei
v
e
or
de
rs
,
l
ab
r
e
sults
,
a
n
d
r
efe
rr
a
ls
b
y
fa
x
or
p
a
p
e
r
.
AI
syst
e
ms
ca
n
now
a
utom
a
t
ica
lly
e
xtr
ac
t
da
t
a
f
rom
s
ca
nn
ed
fa
x
e
s
/
f
orms
a
n
d
rout
e
i
t
.
I
n
t
he
e
C
l
i
n
ica
l
W
or
k
s
surv
e
y
,
us
e
rs
r
e
port
ed
64
%
s
a
v
i
n
g
a
t
l
ea
st
a
n
h
our
p
e
r
da
y
t
h
rou
gh
a
utom
a
t
ed
fa
x
sort
i
n
g
(
[4]
www
.
m
edica
l
ec
onom
ic
s
.
c
om
).
(
T
hi
s
m
a
y
c
ontr
ib
ut
e
to
sm
a
ll
e
r
c
l
i
n
ic
s
achie
v
i
n
g
“
p
a
p
e
rl
e
ss
fa
x
”.)
A
utom
a
t
ed
i
n
b
ox
tools
a
lso
s
i
mpl
e
tr
iage
e
-
pr
e
s
c
r
i
pt
i
ons
a
n
d
r
efe
rr
a
l
r
e
qu
e
sts
.
MGMA
not
e
s
“
tr
iage
o
f
i
n
b
oun
d
c
ommun
ica
t
i
ons
(
p
h
on
e
/
t
e
xt
/
fa
x
)”
a
s
a
top
AI
us
e
ca
s
e
(
[31]
www
.
m
g
m
a
.
c
om
).
S
om
e
v
e
n
d
ors
(
su
ch
a
s
R
e
l
a
ym
ed
I
nt
e
ll
ec
t
a
n
d
P
o
ki
t
D
o
k
/
T
i
tl
e
s
)
t
a
r
ge
t
i
nsur
a
n
ce
v
e
r
ifica
t
i
on
a
n
d
r
efe
rr
a
ls
v
ia
AI
.
IntuitionLabs - Custom AI Software Development
from the leading AI expert Adrien Laurent AI in Private Practice: 2025 Adoption Trends & Statistics
© 2025 IntuitionLabs.ai - North America's Leading AI Software Development Firm for Pharmaceutical & Biotech. All rights reserved. Page 5 of 17
P
a
t
ie
nt
C
ommun
ica
t
i
on
a
n
d
S
ched
ul
i
n
g
.
C
ha
t
b
ots
a
n
d
vo
ice
age
nts
ca
n
a
nsw
e
r
rout
i
n
e
p
a
t
ie
nt
i
nqu
i
r
ie
s
(
e
.
g
.
“
W
he
n
ʼ
s
my
ea
rl
ie
st
a
ppo
i
ntm
e
nt
?”)
a
n
d
b
oo
k
v
i
s
i
ts
24/7.
W
hi
l
e
b
ro
ad
ad
opt
i
on
da
t
a
i
s
l
i
m
i
t
ed
f
or
sm
a
ll
pr
ac
t
ice
s
,
i
n
d
ustry
surv
e
ys
su
gge
st
two
-
t
hi
r
d
s
o
f
hea
lt
hca
r
e
or
ga
n
i
z
a
t
i
ons
a
r
e
now
us
i
n
g
or
c
ons
ide
r
i
n
g
AI
f
or
c
ustom
e
r
-
faci
n
g
a
utom
a
t
i
on
(
[18]
www
.
m
edica
l
ec
onom
ic
s
.
c
om
).
AMA
da
t
a
s
h
ow
only
~8–12
%
o
f
d
o
c
tors
i
n
2025
r
e
port
us
i
n
g
AI
cha
t
b
ots
f
or
p
a
t
ie
nt
m
e
ss
agi
n
g
or
s
ched
ul
i
n
g
(
[32]
www
.
a
m
a
-
a
ssn
.
or
g
),
b
ut
t
hi
s
i
s
a
r
a
p
id
ly
g
row
i
n
g
a
r
ea
.
N
ot
ab
ly
,
on
e
t
e
st
i
mon
ia
l
c
l
ai
m
ed
a
n
AI
a
ss
i
st
a
nt
ha
n
d
l
ed
67
%
o
f
a
ppo
i
ntm
e
nt
b
oo
ki
n
g
r
e
qu
e
sts
i
n
a
n
op
h
t
ha
lmolo
g
y
pr
ac
t
ice
(
[33]
www
.
s
i
m
b
o
.
ai
).
E
v
e
n
if
su
ch
a
n
ecd
ot
e
s
a
r
e
pr
e
l
i
m
i
n
a
ry
,
m
a
ny
pr
ac
t
ice
s
r
e
port
fe
w
e
r
no
-
s
h
ows
a
n
d
highe
r
p
a
t
ie
nt
s
a
t
i
s
fac
t
i
on
w
he
n
r
e
m
i
n
de
rs
a
n
d
r
e
s
ched
ul
i
n
g
a
r
e
a
utom
a
t
ed
.
(
F
or
e
x
a
mpl
e
,
a
n
O
s
F H
ea
lt
hca
r
e
ca
s
e
stu
d
y
r
e
port
ed
mult
-
m
i
l
i
on
s
a
v
i
n
g
s
f
rom
cha
t
b
ots
,
t
h
ou
gh
de
t
ai
l
ed
fig
ur
e
s
v
a
ry
b
y
sour
ce
.)
P
a
t
ie
nt
P
ort
a
l
a
n
d
I
n
-
B
a
s
ke
t
A
utom
a
t
i
on
.
AI
ca
n
d
r
af
t
r
e
spons
e
s
to
p
a
t
ie
nt
port
a
l
m
e
ss
age
s
,
summ
a
r
i
z
e
l
ab
r
e
sults
f
or
p
a
t
ie
nts
,
or
prov
ide
s
i
mpl
e
hea
lt
h
ed
u
ca
t
i
on
a
nsw
e
rs
.
I
n
a
n
AMA
surv
e
y
,
9–10
%
o
f
p
h
ys
icia
ns
r
e
port
ed
us
i
n
g
AI
to
d
r
af
t
port
a
l
r
e
pl
ie
s
(
[34]
www
.
a
m
a
-
a
ssn
.
or
g
).
M
a
ny
pr
ac
t
ice
s
a
r
e
begi
nn
i
n
g
to
t
e
st
or
p
i
lot
t
he
s
e
tools
(
f
or
i
nst
a
n
ce
,
E
p
ic
a
n
d
M
ic
roso
f
t
ha
v
e
bee
n
de
v
e
lop
i
n
g
AI
e
m
ai
l
r
e
spon
de
rs
).
A
lt
h
ou
gh
upt
ake
r
e
m
ai
ns
low
,
i
nt
e
r
e
st
i
s
high
beca
us
e
p
h
ys
icia
ns
o
f
t
e
n
sp
e
n
d
m
a
ny
h
ours
on
i
n
b
ox
m
a
n
age
m
e
nt
.
R
e
v
e
nu
e
C
y
c
l
e
M
a
n
age
m
e
nt
(
RCM
)
a
n
d
C
o
di
n
g
.
AI
-
d
r
i
v
e
n
pl
a
t
f
orms
ca
n
check
c
o
di
n
g
acc
ur
ac
y
,
a
uto
-
ge
n
e
r
a
t
e
bi
ll
i
n
g
c
o
de
s
f
rom
not
e
s
,
a
n
d
e
xp
edi
t
e
i
nsur
a
n
ce
a
pprov
a
ls
.
L
a
r
ge
EHR
a
n
d
bi
ll
i
n
g
c
omp
a
n
ie
s
(
e
.
g
.
C
ha
n
ge
H
ea
lt
hca
r
e
/
O
ptum
,
R
1)
a
r
e
i
n
c
orpor
a
t
i
n
g
AI
f
or
c
l
ai
m
s
c
ru
bbi
n
g
a
n
d
pr
i
or
a
ut
h
or
i
z
a
t
i
on
.
A MGMA
r
e
port
l
i
sts
“
r
e
v
e
nu
e
c
y
c
l
e
m
a
n
age
m
e
nt
us
i
n
g
AI
”
(
f
or
pr
i
or
a
ut
h
,
c
l
ai
m
st
a
tus
,
cha
rt
s
c
ru
bbi
n
g
)
a
mon
g
l
eadi
n
g
us
e
s
(
[35]
www
.
m
g
m
a
.
c
om
).
I
n
pr
ac
t
ice
,
pr
i
v
a
t
e
g
roups
t
ha
t
de
ploy
AI
i
n
RCM
ha
v
e
s
ee
n
fa
st
e
r
bi
ll
i
n
g
c
y
c
l
e
s
a
n
d
fe
w
e
r
de
n
ia
ls
,
t
h
ou
gh
ad
opt
i
on
fig
ur
e
s
i
n
sm
a
ll
o
ffice
s
a
r
e
not
w
ide
ly
pu
b
l
i
s
hed
.
I
t
i
s
e
xp
ec
t
ed
t
ha
t
ad
opt
i
on
i
n
bi
ll
i
n
g
w
i
ll
c
ont
i
nu
e
a
s
r
eg
ul
a
tory
r
e
qu
i
r
e
m
e
nts
(
l
ike
e
PA
m
a
n
da
t
e
s
)
a
n
d
c
o
di
n
g
c
ompl
e
x
i
ty
g
row
.
C
l
i
n
ica
l
D
eci
s
i
on
S
upport
.
W
hi
l
e
st
i
ll
l
e
ss
c
ommon
i
n
sm
a
ll
pr
i
v
a
t
e
c
l
i
n
ic
s
,
AI
i
s
g
r
ad
u
a
lly
e
nt
e
r
i
n
g
t
he
c
l
i
n
ica
l
r
ea
lm
.
E
x
a
mpl
e
s
i
n
c
lu
de
AI
-
a
ss
i
st
ed
diag
nost
ic
s
(
e
.
g
.
s
ki
n
l
e
s
i
on
a
n
a
lys
i
s
on
a
sm
a
rtp
h
on
e
,
or
a
utom
a
t
ed
ECG
i
nt
e
rpr
e
t
a
t
i
on
).
A
not
ab
l
e
ca
s
e
i
s
C
l
e
v
e
l
a
n
d
C
l
i
n
ic
ʼ
s
us
e
o
f
a
n
AI
s
e
ps
i
s
a
l
e
rt
:
t
hi
s
h
osp
i
t
a
l
-
r
ec
or
d
pl
a
t
f
orm
r
ed
u
ced
fa
ls
e
a
l
a
rms
b
y
10
x
a
n
d
i
n
c
r
ea
s
ed
ea
rly
s
e
ps
i
s
ide
nt
ifica
t
i
on
b
y
46
%
(
[26]
n
e
wsroom
.
c
l
e
v
e
l
a
n
dc
l
i
n
ic
.
or
g
).
(
W
hi
l
e
t
hi
s
e
x
a
mpl
e
i
s
f
rom
a
n
18-
h
osp
i
t
a
l
syst
e
m
,
i
t
i
llustr
a
t
e
s
pot
e
nt
ia
l
c
l
i
n
ica
l
be
n
efi
ts
.)
S
om
e
mult
i
sp
ecia
lty
g
roups
a
lso
us
e
AI
r
i
s
k
s
c
or
e
s
to
ide
nt
if
y
diabe
t
ic
c
ompl
ica
t
i
ons
or
h
osp
i
t
a
l
r
ead
m
i
ss
i
on
r
i
s
k
.
A
s
ge
n
e
r
a
t
i
v
e
AI
mo
de
ls
i
mprov
e
,
pr
i
m
a
ry
ca
r
e
d
o
c
tors
a
r
e
e
xplor
i
n
g
LLM
s
to
summ
a
r
i
z
e
p
a
t
ie
nt
hi
stor
ie
s
or
su
gge
st
diffe
r
e
nt
ia
l
diag
nos
e
s
,
b
ut
ro
b
ust
c
l
i
n
ica
l
v
a
l
ida
t
i
on
i
s
on
g
o
i
n
g
.
T
he
s
e
a
ppl
ica
t
i
ons
a
r
e
summ
a
r
i
z
ed
i
n
T
ab
l
e
2
a
lon
g
w
i
t
h
r
e
port
ed
ad
opt
i
on
/
i
mp
ac
t
.
I
n
sum
,
t
he
m
aj
or
ea
rly
w
i
ns
o
f
AI
i
n
pr
i
v
a
t
e
pr
ac
t
ice
a
r
e
stron
g
ly
w
eigh
t
ed
tow
a
r
d
r
ed
u
ci
n
g
rout
i
n
e
wor
k
.
P
r
e
l
i
m
i
n
a
ry
da
t
a
i
n
dica
t
e
t
ha
t
w
he
n
i
mpl
e
m
e
nt
ed
t
h
ou
gh
t
f
ully
(
a
n
d
w
i
t
h
c
l
i
n
icia
n
ov
e
rs
igh
t
),
ad
m
i
n
i
str
a
t
i
v
e
AI
ca
n
r
ec
oup
m
u
l
t
i
p
le
st
aff
-
h
ours
p
e
r
cli
n
icia
n
p
e
r
da
y
.
T
hi
s
tr
a
nsl
a
t
e
s
di
r
ec
tly
i
nto
c
ost
s
a
v
i
n
g
s
or
ca
p
aci
ty
to
s
ee
mor
e
p
a
t
ie
nts
.
CMS
ʼ
s
e
st
i
m
a
t
e
t
ha
t
77
%
o
f
hea
lt
hca
r
e
wor
ke
rs
w
a
st
e
45
m
i
nut
e
s
/
da
y
on
i
n
efficie
nt
wor
kf
lows
(
f
our
w
eek
s
lost
a
nnu
a
lly
)
un
de
rs
c
or
e
s
t
he
a
v
ai
l
ab
l
e
opportun
i
ty
(
[36]
www
.
ic
t
hea
lt
h
.
or
g
).
P
r
ac
t
i
t
i
on
e
rs
v
ie
w
a
utom
a
t
i
on
o
f
su
ch
t
a
s
k
s
a
s
a
s
a
n
i
ty
-
s
a
v
i
n
g
solut
i
on
:
92
%
o
f
hea
lt
hca
r
e
l
eade
rs
s
a
y
AI
w
i
ll
b
oost
op
e
r
a
t
i
on
a
l
efficie
n
c
y
,
a
n
d
84
%
o
f
d
o
c
tors
be
l
ie
v
e
i
t
w
i
ll
a
utom
a
t
e
t
edi
ous
t
a
s
k
s
(
[14]
www
.
de
lo
i
tt
e
.
c
om
)
(
[19]
www
.
ic
t
hea
lt
h
.
or
g
).
T
ab
l
e
2.
C
o
mm
on
AI A
pp
lica
t
i
ons
i
n
P
r
i
v
a
t
e
P
r
ac
t
ice
s
(
E
x
am
p
le
s
o
f
us
e
ca
s
e
s
,
too
l
s
,
a
n
d
im
p
ac
t
f
ro
m
r
ece
nt
stu
die
s
a
n
d
i
n
d
ustry
r
e
ports
)
AI A
ppl
ica
t
i
on
D
e
s
c
r
i
pt
i
on
/
E
x
a
mpl
e
T
ools
A
d
opt
i
on
/
I
mp
ac
t
C
l
i
n
ica
l
D
o
c
um
e
nt
a
t
i
on
A
ss
i
st
a
nts
AI
s
c
r
ibe
s
t
ha
t
tr
a
ns
c
r
ibe
a
n
d
stru
c
tur
e
p
h
ys
icia
n
–
p
a
t
ie
nt
e
n
c
ount
e
rs
(
e
.
g
.
S
uno
h
.
ai
,
A
b
r
idge
,
S
u
ki
,
N
u
a
n
ce
D
r
ag
on
A
m
bie
nt
)
~72
%
o
f
AI
-
us
i
n
g
pr
ac
t
ice
s
r
e
ly
on
a
m
bie
nt
s
c
r
ibe
s
(
S
uno
h
.
ai
)
f
or
d
o
c
um
e
nt
a
t
i
on
,
w
i
t
h
~66
%
o
f
t
h
os
e
us
e
rs
s
a
v
i
n
g
1–4+
h
ours
/
da
y
(
[3]
www
.
m
edica
l
ec
onom
ic
s
.
c
om
).
A
n
AMA
surv
e
y
f
oun
d
22
%
o
f
pr
i
v
a
t
e
p
h
ys
icia
ns
us
e
AI
to
d
r
af
t
not
e
s
/
c
o
di
n
g
(
[30]
www
.
a
m
a
-
a
ssn
.
or
g
).
B
ig
t
i
m
e
-
s
a
v
i
n
g
s
r
e
port
ed
.
F
a
x
/
F
orm
&
D
o
c
um
e
nt
M
a
n
age
m
e
nt
A
utom
a
t
i
on
o
f
i
n
c
om
i
n
g
i
n
f
orm
a
t
i
on
(
fa
x
e
s
,
l
ab
r
e
ports
,
r
efe
rr
a
l
f
orms
)
~64
%
o
f
pr
ac
t
ice
s
us
i
n
g
AI
r
e
port
s
a
v
i
n
g
≥1
h
our
/
da
y
on
fa
x
sort
i
n
g
a
n
d
pro
ce
ss
i
n
g
(
[4]
www
.
m
edica
l
ec
onom
ic
s
.
c
om
).
(
B
ehi
n
d
s
ce
n
e
s
,
t
hi
s
r
ed
u
ce
s
lost
p
a
p
e
rwor
k
a
n
d
st
aff
wor
k
.)
V
e
n
d
ors
now
OCR
a
n
d
rout
e
f
orms
a
utom
a
t
ica
lly
.
IntuitionLabs - Custom AI Software Development
from the leading AI expert Adrien Laurent AI in Private Practice: 2025 Adoption Trends & Statistics
© 2025 IntuitionLabs.ai - North America's Leading AI Software Development Firm for Pharmaceutical & Biotech. All rights reserved. Page 6 of 17
AI A
ppl
ica
t
i
on
D
e
s
c
r
i
pt
i
on
/
E
x
a
mpl
e
T
ools
A
d
opt
i
on
/
I
mp
ac
t
P
a
t
ie
nt
C
ommun
ica
t
i
on
&
S
ched
ul
i
n
g
C
ha
t
b
ots
a
n
d
vo
ice
age
nts
f
or
a
ppo
i
ntm
e
nt
b
oo
ki
n
g
a
n
d
FAQ
s
(
e
.
g
.
c
onv
e
rs
a
t
i
on
a
l
AI
s
ched
ul
e
rs
,
r
e
m
i
n
de
r
b
ots
)
I
n
i
n
d
ustry
surv
e
ys
~66
%
o
f
hea
lt
hca
r
e
or
g
s
us
e
or
pl
a
n
AI
(
v
a
r
i
ous
us
e
s
)
(
[18]
www
.
m
edica
l
ec
onom
ic
s
.
c
om
).
AMA
fi
n
d
s
8–12
%
o
f
d
o
c
tors
us
i
n
g
cha
t
b
ots
f
or
p
a
t
ie
nt
-
faci
n
g
t
a
s
k
s
(
[32]
www
.
a
m
a
-
a
ssn
.
or
g
).
E
a
rly
ad
opt
e
rs
r
e
port
fe
w
e
r
no
-
s
h
ows
a
n
d
mor
e
p
a
t
ie
nt
e
n
gage
m
e
nt
,
t
h
ou
gh
w
ide
us
e
i
s
n
a
s
ce
nt
.
R
e
v
e
nu
e
C
y
c
l
e
A
utom
a
t
i
on
(
B
i
ll
i
n
g
)
AI
f
or
c
o
di
n
g
,
c
l
ai
ms
,
pr
i
or
a
ut
h
or
i
z
a
t
i
on
(
e
.
g
.
a
uto
c
o
de
su
gge
st
i
ons
,
AI
p
a
y
e
r
s
c
ru
bbi
n
g
)
MGMA
r
e
ports
RCM
a
n
d
pr
i
or
-
a
ut
h
a
s
l
eadi
n
g
us
e
ca
s
e
s
(
[35]
www
.
m
g
m
a
.
c
om
).
P
r
ac
t
ice
s
r
e
port
fa
st
e
r
c
l
ai
ms
pro
ce
ss
i
n
g
a
n
d
fe
w
e
r
de
n
ia
ls
.
(
F
orm
a
l
ROI
da
t
a
l
i
m
i
t
ed
,
b
ut
on
e
i
n
d
ustry
sour
ce
not
ed
~60
%
o
f
AI
ad
opt
e
rs
e
xp
ec
t
n
ea
r
-
t
e
rm
pos
i
t
i
v
e
ROI
on
G
e
n
AI
pro
jec
ts
(
[37]
www
.
m
akeb
ot
.
ai
).)
P
a
t
ie
nt
P
ort
a
l
M
a
n
age
m
e
nt
A
utom
a
t
ed
d
r
af
t
i
n
g
o
f
port
a
l
m
e
ss
age
r
e
spons
e
s
or
summ
a
r
i
z
i
n
g
l
ab
s
f
or
p
a
t
ie
nts
(
LLM
s
,
sm
a
rt
t
e
mpl
a
t
e
s
)
AMA
da
t
a
:
~9
%
o
f
p
h
ys
icia
ns
us
e
AI
to
ge
n
e
r
a
t
e
port
a
l
m
e
ss
age
r
e
pl
ie
s
(
[34]
www
.
a
m
a
-
a
ssn
.
or
g
).
U
s
age
i
s
low
b
ut
g
row
i
n
g
.
S
om
e
v
e
n
d
ors
now
o
ffe
r
AI
e
m
ai
l
a
ss
i
st
a
nts
;
ot
he
rs
i
nt
eg
r
a
t
e
LLM
summ
a
r
ie
s
o
f
r
ec
or
d
s
to
r
ed
u
ce
r
eadi
n
g
t
i
m
e
.
D
eci
s
i
on
S
upport
&
P
r
edic
t
i
v
e
M
o
de
ls
AI
tools
f
or
diag
nos
i
s
or
r
i
s
k
pr
edic
t
i
on
(
e
.
g
.
s
e
ps
i
s
a
l
e
rts
,
diabe
t
e
s
r
i
s
k
s
c
or
e
s
,
i
m
agi
n
g
a
n
a
lys
i
s
)
L
i
m
i
t
ed
i
n
sm
a
ll
pr
ac
t
ice
s
;
mor
e
c
ommon
i
n
l
a
r
ge
syst
e
ms
.
N
ot
ab
l
e
e
x
a
mpl
e
:
a
n
AI
s
e
ps
i
s
a
l
e
rt
a
t
C
l
e
v
e
l
a
n
d
C
l
i
n
ic
r
ed
u
ced
fa
ls
e
pos
i
t
i
v
e
s
10
x
a
n
d
ide
nt
ified
46
%
mor
e
ca
s
e
s
(
[26]
n
e
wsroom
.
c
l
e
v
e
l
a
n
dc
l
i
n
ic
.
or
g
).
F
utur
e
:
b
ro
ade
r
ad
opt
i
on
o
f
v
a
l
ida
t
ed
AI
diag
nost
ic
s
i
s
e
xp
ec
t
ed
.
P
r
ac
t
ice
S
i
z
e
a
n
d
S
p
ecia
l
i
z
a
t
i
on
A
d
opt
i
on
a
lso
v
a
r
ie
s
b
y
pr
ac
t
ice
s
i
z
e
a
n
d
sp
ecia
lty
.
L
a
r
ge
g
roup
pr
ac
t
ice
s
(
mult
i
-
sp
ecia
lty
c
l
i
n
ic
s
,
ur
ge
nt
-
ca
r
e
chai
ns
)
t
e
n
d
to
ha
v
e
mor
e
r
e
sour
ce
s
to
tr
ia
l
AI
a
n
d
be
n
efi
t
f
rom
st
a
n
da
r
di
z
a
t
i
on
.
S
olo
a
n
d
v
e
ry
sm
a
ll
pr
ac
t
ice
s
o
f
t
e
n
stru
gg
l
e
w
i
t
h
i
nt
eg
r
a
t
i
on
:
t
he
y
l
ack
I
T
st
aff
to
v
e
t
tools
or
n
eg
ot
ia
t
e
i
nt
eg
r
a
t
i
ons
w
i
t
h
t
hei
r
EHR
,
a
n
d
t
he
r
e
l
a
t
i
v
e
c
ost
p
e
r
prov
ide
r
i
s
highe
r
.
A
n
AMA
a
n
a
lys
i
s
not
e
s
t
ha
t
c
ost
i
s
a
c
ons
i
st
e
nt
i
ssu
e
:
e
mploy
ed
p
h
ys
icia
ns
o
f
t
e
n
be
n
efi
t
f
rom
t
hei
r
or
ga
n
i
z
a
t
i
on
c
ov
e
r
i
n
g
i
mpl
e
m
e
nt
a
t
i
on
e
xp
e
ns
e
s
,
w
he
r
ea
s
pr
i
v
a
t
e
d
o
c
tors
must
un
de
rt
ake
v
e
tt
i
n
g
a
n
d
c
ontr
ac
t
i
n
g
on
t
hei
r
own
(
[8]
www
.
a
m
a
-
a
ssn
.
or
g
).
S
p
ecia
l
i
sts
us
i
n
g
c
ommon
pl
a
t
f
orms
(
l
ike
E
p
ic
)
m
a
y
ge
t
e
m
bedded
AI
fea
tur
e
s
,
w
hi
l
e
sm
a
ll
pr
ac
t
ice
s
us
i
n
g
l
igh
tw
eigh
t
EHR
s
m
a
y
w
ai
t
f
or
v
e
n
d
ors
to
up
da
t
e
.
U
r
ba
n
/
rur
a
l
diffe
r
e
n
ce
s
a
r
e
s
ig
n
ifica
nt
:
fede
r
a
l
da
t
a
s
h
ow
~77
%
o
f
ur
ba
n
h
osp
i
t
a
ls
us
i
n
g
pr
edic
t
i
v
e
AI
v
e
rsus
only
~46
%
o
f
rur
a
l
c
r
i
t
ica
l
-
acce
ss
h
osp
i
t
a
ls
(
[38]
www
.
hea
lt
hi
t
.
g
ov
).
B
y
a
n
a
lo
g
y
,
i
n
de
p
e
n
de
nt
rur
a
l
c
l
i
n
ic
s
s
i
m
i
l
a
rly
l
ag
behi
n
d
syst
e
m
-
affi
l
ia
t
ed
c
l
i
n
ic
s
.
I
n
s
h
ort
,
l
a
r
ge
r
,
syst
e
m
-
support
ed
pr
ac
t
ice
s
l
ead
i
n
ad
opt
i
on
;
typ
ica
l
sm
a
ll
g
roup
pr
ac
t
ice
s
a
r
e
mor
e
ca
ut
i
ous
a
n
d
slow
e
r
-
mov
i
n
g
.
P
h
ys
icia
n
a
n
d
S
t
aff
A
tt
i
tu
de
s
C
l
i
n
icia
n
e
nt
h
us
ia
sm
f
or
AI
i
s
ge
n
e
r
a
lly
high
a
n
d
r
i
s
i
n
g
.
I
n
2024,
68
%
o
f
U
.
S
.
p
h
ys
icia
ns
s
a
w
defi
n
i
t
e
or
som
e
ad
v
a
nt
age
i
n
AI
tools
(
[2]
www
.
a
m
a
-
a
ssn
.
or
g
),
up
f
rom
65
%
t
he
y
ea
r
pr
i
or
.
O
nly
~9
%
o
f
d
o
c
tors
w
e
r
e
mostly
agai
nst
AI
(
[2]
www
.
a
m
a
-
a
ssn
.
or
g
).
M
a
ny
p
h
ys
icia
ns
r
e
port
t
ha
t
AI
low
e
rs
wor
k
lo
ad
s
a
n
d
b
urnout
:
79
%
o
f
hea
lt
hca
r
e
wor
ke
rs
be
l
ie
v
e
AI
w
i
ll
i
mprov
e
out
c
om
e
s
(
[20]
www
.
ic
t
hea
lt
h
.
or
g
),
a
n
d
84
%
ag
r
ee
i
t
ca
n
a
utom
a
t
e
r
e
p
e
t
i
t
i
v
e
t
a
s
k
s
(
[19]
www
.
ic
t
hea
lt
h
.
or
g
).
AMA
surv
e
ys
sp
ecifica
lly
s
h
ow
t
ha
t
d
o
c
tors
e
xp
ec
t
t
a
s
k
s
l
ike
not
e
-
t
aki
n
g
,
i
n
b
ox
m
a
n
age
m
e
nt
,
a
n
d
d
ru
g
or
de
r
i
n
g
to
be
n
efi
t
most
f
rom
AI
.
F
or
e
x
a
mpl
e
,
57
%
r
a
n
ked
a
utom
a
t
i
on
o
f
p
a
p
e
rwor
k
a
s
t
he
top
AI
opportun
i
ty
(
[2]
www
.
a
m
a
-
a
ssn
.
or
g
).
D
o
c
tors
a
lso
v
a
lu
e
tools
t
ha
t
“
e
mpow
e
r
t
he
m
”
r
a
t
he
r
t
ha
n
r
e
pl
ace
t
he
m
;
a
m
aj
or
i
ty
(57–88
%
)
i
n
dica
t
e
t
ha
t
fea
tur
e
s
l
ike
dedica
t
ed
feedback
cha
nn
e
ls
,
pr
i
v
ac
y
a
ssur
a
n
ce
,
a
n
d
i
nt
eg
r
a
t
i
on
a
r
e
c
r
i
t
ica
l
f
or
ad
opt
i
on
(
[39]
www
.
a
m
a
-
a
ssn
.
or
g
).
N
on
e
t
he
l
e
ss
,
tr
a
nsp
a
r
e
nt
trust
i
s
a
c
on
ce
rn
.
P
a
t
ie
nts
ha
v
e
low
e
r
trust
i
n
m
edica
l
AI
,
e
sp
ecia
lly
f
or
di
r
ec
t
ca
r
e
:
only
59
%
o
f
p
a
t
ie
nts
surv
e
y
ed
trust
AI
to
i
mprov
e
t
hei
r
ca
r
e
,
vs
.
79
%
o
f
d
o
c
tors
(
[20]
www
.
ic
t
hea
lt
h
.
or
g
).
E
v
e
n
IntuitionLabs - Custom AI Software Development
from the leading AI expert Adrien Laurent AI in Private Practice: 2025 Adoption Trends & Statistics
© 2025 IntuitionLabs.ai - North America's Leading AI Software Development Firm for Pharmaceutical & Biotech. All rights reserved. Page 7 of 17
a
mon
g
c
l
i
n
icia
ns
,
25
%
r
e
m
ai
n
mor
e
s
ke
pt
ica
l
t
ha
n
e
nt
h
us
ia
st
ic
ab
out
AI
(
[40]
www
.
a
m
a
-
a
ssn
.
or
g
).
T
he
AMA
not
e
s
t
ha
t
fea
rs
ab
out
da
t
a
pr
i
v
ac
y
,
a
l
g
or
i
t
h
m
ic
“
b
l
ack
b
ox
e
s
,”
l
iabi
l
i
ty
f
or
AI
e
rrors
,
a
n
d
poor
i
nt
eg
r
a
t
i
on
w
i
t
h
EHR
s
a
r
e
hi
n
de
r
i
n
g
som
e
d
o
c
tors
(
[10]
www
.
a
m
a
-
a
ssn
.
or
g
).
I
n
on
e
a
n
a
lys
i
s
,
p
h
ys
icia
ns
i
n
sm
a
ll
pr
ac
t
ice
s
w
e
r
e
p
a
rt
ic
ul
a
rly
w
a
ry
o
f
op
a
qu
e
tools
,
pr
efe
rr
i
n
g
“
c
l
i
n
ica
lly
v
a
l
ida
t
ed
”
a
n
d
tr
a
nsp
a
r
e
nt
solut
i
ons
(
[41]
www
.
h
n
a
-
n
e
t
.
c
om
).
O
v
e
r
a
ll
,
h
ow
e
v
e
r
,
e
xp
e
rt
p
a
n
e
ls
a
n
d
AMA
g
u
ida
n
ce
ur
ge
ca
ut
i
ous
,
p
ha
s
ed
ad
opt
i
on
:
f
or
i
nst
a
n
ce
,
st
a
rt
i
n
g
w
i
t
h
us
age
i
n
d
o
c
um
e
nt
a
t
i
on
or
tr
iage
w
he
r
e
i
mp
ac
t
i
s
ea
s
ie
r
to
ga
u
ge
(
[42]
www
.
h
n
a
-
n
e
t
.
c
om
),
r
a
t
he
r
t
ha
n
l
ea
p
f
ro
ggi
n
g
to
high
-
st
ake
s
diag
nost
ic
s
.
D
r
i
v
e
rs
o
f
AI A
d
opt
i
on
S
e
v
e
r
a
l
ke
y
fac
tors
a
r
e
d
r
i
v
i
n
g
AI
upt
ake
i
n
pr
i
v
a
t
e
pr
ac
t
ice
s
e
tt
i
n
g
s
:
E
fficie
n
c
y
a
n
d
C
ost
P
r
e
ssur
e
.
P
r
ac
t
ice
s
a
r
e
un
de
r
c
onst
a
nt
pr
e
ssur
e
to
s
ee
mor
e
p
a
t
ie
nts
w
i
t
h
l
i
m
i
t
ed
r
e
sour
ce
s
.
AI
ʼ
s
prom
i
s
e
o
f
a
utom
a
t
i
n
g
t
a
s
k
s
tr
a
nsl
a
t
e
s
to
pot
e
nt
ia
l
r
e
v
e
nu
e
gai
ns
(
v
ia
mor
e
v
i
s
i
ts
)
or
c
ost
s
a
v
i
n
g
s
.
O
r
ga
n
i
z
a
t
i
ons
a
r
e
mot
i
v
a
t
ed
b
y
b
ot
h
l
ab
or
s
h
ort
age
s
a
n
d
fi
n
a
n
cia
l
sust
ai
n
abi
l
i
ty
:
on
e
i
n
d
ustry
a
n
a
lyst
not
ed
t
ha
t
hea
lt
hca
r
e
l
eade
rs
ad
opt
AI
not
only
f
or
ca
r
e
i
mprov
e
m
e
nt
b
ut
to
“
str
e
n
g
t
he
n
sust
ai
n
abi
l
i
ty
”
(
[43]
c
lou
dga
t
e
.
hea
lt
hca
r
ei
tn
e
ws
.
c
om
).
P
hi
l
i
ps
ʼ
surv
e
y
qu
a
nt
ified
t
he
i
rony
:
c
l
i
n
icia
ns
sp
e
n
d
ab
out
4
w
eek
s
p
e
r
y
ea
r
dea
l
i
n
g
w
i
t
h
a
vo
idab
l
e
da
t
a
f
r
ag
m
e
nt
a
t
i
on
,
a
n
d
35
%
r
e
port
r
i
s
i
n
g
p
a
p
e
rwor
k
t
i
m
e
(
[36]
www
.
ic
t
hea
lt
h
.
or
g
).
I
n
t
ha
t
c
ont
e
xt
,
AI
i
s
v
ie
w
ed
a
s
a
pr
ag
m
a
t
ic
fi
x
.
T
ech
nolo
g
y
M
a
tur
a
t
i
on
.
T
he
m
a
tur
i
ty
a
n
d
acce
ss
ibi
l
i
ty
o
f
AI
tools
ha
v
e
i
mprov
ed
.
A
m
bie
nt
s
c
r
ibi
n
g
,
on
ce
e
rror
-
pron
e
,
now
us
e
s
ad
v
a
n
ced
NLP
mo
de
ls
tr
ai
n
ed
on
m
edica
l
l
a
n
g
u
age
.
C
lou
d
API
s
a
llow
pr
ac
t
ice
s
to
“
b
olt
on
”
AI
w
i
t
h
out
h
u
ge
lo
ca
l
i
nv
e
stm
e
nt
.
EHR
c
omp
a
n
ie
s
a
r
e
baki
n
g
AI
i
nto
up
g
r
ade
s
(
s
ee
b
ox
be
low
on
A
t
he
n
ahea
lt
h
).
C
omp
e
t
i
t
i
on
a
mon
g
v
e
n
d
ors
ha
s
a
lso
d
r
i
v
e
n
pr
ice
s
d
own
:
f
or
i
nst
a
n
ce
,
op
e
n
-
acce
ss
LLM
s
a
n
d
c
ommo
di
t
i
z
ed
GP
U
i
n
f
r
a
stru
c
tur
e
m
ea
n
t
ha
t
e
v
e
n
sm
a
ll
fi
rms
ca
n
de
v
e
lop
cha
t
b
ots
or
i
m
age
a
n
a
lyz
e
rs
.
A
s
t
ech
nolo
g
y
ba
rr
ie
rs
fa
ll
,
mor
e
pr
ac
t
ice
s
s
ee
AI
solut
i
ons
w
i
t
hi
n
r
each
.
P
h
ys
icia
n
I
nt
e
r
e
st
.
M
a
ny
d
o
c
tors
a
r
e
c
ur
i
ous
ab
out
AI
a
n
d
w
a
nt
t
i
m
e
s
a
v
i
n
g
s
.
T
he
AMA
surv
e
y
s
h
ow
ed
t
ha
t
a
plur
a
l
i
ty
i
n
b
ot
h
pr
i
v
a
t
e
a
n
d
e
mploy
ed
s
e
tt
i
n
g
s
ag
r
ee
t
ha
t
“
i
t
i
s
(
or
w
i
ll
bec
om
e
)
t
he
st
a
n
da
r
d
o
f
ca
r
e
”
to
us
e
AI
tools
(
[44]
www
.
a
m
a
-
a
ssn
.
or
g
).
S
om
e
sp
ecia
lt
ie
s
ha
v
e
bec
om
e
ea
rly
ad
opt
e
rs
(
e
.
g
.
r
adi
olo
g
y
,
p
a
t
h
olo
g
y
,
de
rm
a
tolo
g
y
)
a
n
d
t
he
y
he
lp
norm
a
l
i
z
e
AI
.
Y
oun
ge
r
c
l
i
n
icia
ns
a
lso
t
e
n
d
to
ha
v
e
mor
e
fa
m
i
l
ia
r
i
ty
w
i
t
h
digi
t
a
l
tools
a
n
d
pus
h
f
or
AI
fea
tur
e
s
.
V
e
n
d
or
P
us
h
a
n
d
M
a
r
ke
t
i
n
g
.
EHR
v
e
n
d
ors
a
n
d
st
a
rtups
a
r
e
p
a
ss
i
on
a
t
e
ly
p
i
t
chi
n
g
AI
to
pr
ac
t
ice
s
.
A
t
he
n
ahea
lt
h
ʼ
s
A
u
g
ust
2025
r
e
l
ea
s
e
o
f
a
n
“
AI
-
n
a
t
i
v
e
”
EHR
pl
a
t
f
orm
i
s
a
ca
s
e
i
n
po
i
nt
:
i
t
prom
i
s
e
s
t
ha
t
e
v
e
ry
on
e
o
f
i
ts
160,000
prov
ide
rs
w
i
ll
i
nst
a
ntly
ge
t
n
e
w
AI
fea
tur
e
s
(
d
o
c
um
e
nt
s
e
rv
ice
s
,
c
l
i
n
ica
l
summ
a
r
ie
s
,
i
nt
e
ll
ige
nt
wor
kf
lows
)
v
ia
c
lou
d
up
da
t
e
s
(
[45]
www
.
fie
r
cehea
lt
hca
r
e
.
c
om
).
E
p
ic
,
C
e
rn
e
r
,
A
lls
c
r
i
pts
a
n
d
ot
he
rs
s
i
m
i
l
a
rly
ad
v
e
rt
i
s
e
AI
mo
d
ul
e
s
(
e
.
g
.
E
p
ic
ʼ
s
N
ot
e
A
ss
i
st
,
C
e
rn
e
r
ʼ
s
P
a
t
ie
nt
C
a
nv
a
s
).
M
or
e
ov
e
r
,
t
hi
r
d
-
p
a
rty
st
a
rtups
(
d
r
ch
rono
,
A
u
g
m
edi
x
,
N
ot
ab
l
e
H
ea
lt
h
,
e
t
c
.)
agg
r
e
ss
i
v
e
ly
m
a
r
ke
t
to
pr
ac
t
ice
s
.
T
hi
s
v
e
n
d
or
-
d
r
i
v
e
n
mom
e
ntum
m
ea
ns
t
ha
t
pr
ac
t
ice
s
o
f
t
e
n
e
n
c
ount
e
r
AI
o
ffe
r
i
n
g
s
w
he
n
s
eeki
n
g
rout
i
n
e
so
f
tw
a
r
e
up
da
t
e
s
,
pus
hi
n
g
ad
opt
i
on
.
R
eg
ul
a
tory
a
n
d
R
ei
m
b
urs
e
m
e
nt
I
n
ce
nt
i
v
e
s
.
A
lt
h
ou
gh
t
he
r
e
a
r
e
no
di
r
ec
t
fede
r
a
l
su
b
s
idie
s
f
or
AI
i
n
o
ffice
s
,
p
a
r
a
ll
e
ls
to
t
he
EHR M
ea
n
i
n
gf
ul
U
s
e
e
r
a
e
x
i
st
.
P
a
yors
a
n
d
r
eg
ul
a
tors
a
r
e
begi
nn
i
n
g
to
e
n
c
our
age
da
t
a
-
d
r
i
v
e
n
ca
r
e
.
F
or
e
x
a
mpl
e
,
CMS
a
n
d
c
omm
e
r
cia
l
i
nsur
e
rs
a
r
e
e
xp
e
r
i
m
e
nt
i
n
g
w
i
t
h
AI
-
ba
s
ed
pr
e
-
a
ut
h
or
i
z
a
t
i
ons
a
n
d
r
e
mot
e
mon
i
tor
i
n
g
c
o
de
s
.
I
n
som
e
v
a
lu
e
-
ba
s
ed
c
ontr
ac
ts
,
efficie
n
c
y
be
n
ch
m
a
r
k
s
m
a
y
i
n
di
r
ec
tly
r
e
w
a
r
d
AI
us
age
.
I
nt
e
rn
a
t
i
on
a
lly
,
n
a
t
i
on
a
l
hea
lt
h
syst
e
ms
(
U
K
ʼ
s
NHS
,
D
a
t
a
.
g
ov
i
n
i
t
ia
t
i
v
e
s
i
n
C
a
n
ada
,
e
t
c
.)
a
r
e
f
un
di
n
g
AI
p
i
lots
t
ha
t
tr
ick
l
e
i
nto
pr
i
v
a
t
e
sp
ecia
lt
ie
s
.
R
eg
ul
a
tory
acce
pt
a
n
ce
(
FDA
-
c
l
ea
r
ed
AI
de
v
ice
s
now
num
be
r
ov
e
r
a
t
h
ous
a
n
d
(
[16]
www
.
m
edica
l
ec
onom
ic
s
.
c
om
))
a
lso
r
ea
ssur
e
s
pr
ac
t
ice
s
t
ha
t
AI
ca
n
be
s
afe
ly
i
nt
eg
r
a
t
ed
.
H
e
n
ce
,
a
c
on
f
lu
e
n
ce
o
f
n
eed
,
opportun
i
ty
,
a
n
d
supply
i
s
b
oost
i
n
g
ad
opt
i
on
.
P
r
ac
t
ice
s
to
da
y
o
f
t
e
n
v
ie
w
AI
a
s
“
a
not
he
r
tool
i
n
t
he
tool
ki
t
”
f
or
str
ea
ml
i
n
i
n
g
op
e
r
a
t
i
ons
.
S
ee
T
ab
l
e
2
f
or
h
ow
t
he
s
e
tools
fi
t
i
nto
typ
ica
l
pr
ac
t
ice
t
a
s
k
s
,
a
n
d
T
ab
l
e
1
f
or
m
ea
sur
e
s
o
f
ad
opt
i
on
.
B
a
rr
ie
rs
a
n
d
C
ha
ll
e
n
ge
s
D
e
sp
i
t
e
t
he
s
e
d
r
i
v
e
rs
,
pr
i
v
a
t
e
pr
ac
t
ice
ad
opt
i
on
face
s
s
ig
n
ifica
nt
i
mp
edi
m
e
nts
:
IntuitionLabs - Custom AI Software Development
from the leading AI expert Adrien Laurent AI in Private Practice: 2025 Adoption Trends & Statistics
© 2025 IntuitionLabs.ai - North America's Leading AI Software Development Firm for Pharmaceutical & Biotech. All rights reserved. Page 8 of 17
C
ost
a
n
d
F
i
n
a
n
cia
l
R
i
s
k
.
T
he
up
f
ront
i
nv
e
stm
e
nt
(
so
f
tw
a
r
e
l
ice
n
ce
s
,
tr
ai
n
i
n
g
,
i
mpl
e
m
e
nt
a
t
i
on
support
)
ca
n
be
su
b
st
a
nt
ia
l
.
U
nl
ike
l
a
r
ge
h
osp
i
t
a
l
syst
e
ms
,
sm
a
ll
pr
ac
t
ice
s
usu
a
lly
ha
v
e
no
I
T
de
p
a
rtm
e
nt
to
n
eg
ot
ia
t
e
c
ontr
ac
ts
or
ab
sor
b
p
i
lot
loss
e
s
.
AMA
p
h
ys
icia
ns
f
r
e
qu
e
ntly
ci
t
e
c
ost
a
s
a
pro
hibi
t
i
v
e
fac
tor
(
[8]
www
.
a
m
a
-
a
ssn
.
or
g
)
(
[46]
www
.
a
m
a
-
a
ssn
.
or
g
).
E
v
e
n
f
or
c
lou
d
-
ba
s
ed
S
aa
S
,
su
b
s
c
r
i
pt
i
on
fee
s
a
n
d
i
nt
eg
r
a
t
i
on
c
osts
add
up
a
n
d
m
a
y
not
fi
t
t
igh
t
pr
ac
t
ice
b
u
dge
ts
.
M
or
e
ov
e
r
,
t
he
ROI
i
s
not
a
lw
a
ys
i
mm
edia
t
e
:
if
a
pr
ac
t
ice
d
o
e
sn
ʼ
t
ca
ptur
e
mor
e
p
a
t
ie
nts
or
bi
ll
mor
e
d
u
e
to
AI
,
t
he
c
ost
ca
n
fee
l
un
j
ust
ified
.
T
ech
n
ica
l
I
nt
eg
r
a
t
i
on
.
M
a
ny
pr
ac
t
ice
s
us
e
EHR
/
CMS
syst
e
ms
t
ha
t
a
r
e
out
da
t
ed
or
ha
v
e
poor
i
nt
e
rop
e
r
abi
l
i
ty
.
I
nt
eg
r
a
t
i
n
g
n
e
w
AI
tools
w
i
t
h
t
he
EHR
ca
n
r
e
qu
i
r
e
t
ech
n
ica
l
wor
kf
lows
(
API
,
HL
7
da
t
a
e
x
cha
n
ge
,
s
ec
ur
i
ty
c
ompl
ia
n
ce
).
F
or
i
nst
a
n
ce
,
if
a
n
AI
s
c
r
ibe
d
o
e
sn
ʼ
t
“
t
a
l
k
”
to
a
n
EHR
,
st
aff
must
c
opy
-
p
a
st
e
not
e
s
,
defea
t
i
n
g
efficie
n
c
y
.
L
ack
o
f
st
a
n
da
r
d
s
ca
n
l
ead
to
v
e
n
d
ors
c
r
ea
t
i
n
g
on
e
-
o
ff
c
onn
ec
tors
.
P
r
ac
t
ice
s
r
e
port
f
r
ic
t
i
on
i
n
on
b
o
a
r
di
n
g
AI
solut
i
ons
t
ha
t
a
r
e
not
s
ea
ml
e
ssly
e
m
bedded
i
n
t
hei
r
e
x
i
st
i
n
g
e
l
ec
tron
ic
syst
e
ms
(
[10]
www
.
a
m
a
-
a
ssn
.
or
g
).
D
a
t
a
Q
u
a
l
i
ty
a
n
d
P
r
i
v
ac
y
.
AI
qu
a
l
i
ty
de
p
e
n
d
s
on
da
t
a
.
S
m
a
ll
e
r
pr
ac
t
ice
s
m
a
y
ha
v
e
poor
da
t
a
h
y
gie
n
e
(
i
n
c
ompl
e
t
e
r
ec
or
d
s
,
i
n
c
ons
i
st
e
nt
c
o
di
n
g
)
w
hich
l
i
m
i
ts
AI
effec
t
i
v
e
n
e
ss
.
I
n
de
x
i
n
g
a
n
d
tr
ai
n
i
n
g
on
a
pr
ac
t
ice
ʼ
s
own
p
a
t
ie
nt
da
t
a
r
e
qu
i
r
e
s
i
n
f
orm
a
t
ic
s
eff
ort
most
sm
a
ll
o
ffice
s
l
ack
.
A
ddi
t
i
on
a
lly
,
HIPAA
a
n
d
p
a
t
ie
nt
pr
i
v
ac
y
l
a
ws
i
mpos
e
c
onstr
ai
nts
:
a
ny
AI
t
ha
t
us
e
s
p
a
t
ie
nt
-
ide
nt
ifiab
l
e
da
t
a
(
e
.
g
.
c
lou
d
-
ba
s
ed
tr
a
ns
c
r
i
pt
i
on
)
must
be
f
ully
c
ompl
ia
nt
.
S
om
e
d
o
c
tors
worry
ab
out
s
e
n
di
n
g
p
a
t
ie
nt
not
e
s
to
a
cha
t
b
ot
(
e
.
g
.
a
c
lou
d
LLM
)
d
u
e
to
c
on
fide
nt
ia
l
i
ty
r
i
s
k
.
S
tr
ic
t
pr
i
v
ac
y
g
u
a
r
a
nt
ee
s
a
n
d
b
us
i
n
e
ss
-
a
sso
cia
t
e
ag
r
ee
m
e
nts
a
r
e
m
a
n
da
tory
,
a
n
d
not
a
ll
AI
v
e
n
d
ors
ea
s
i
ly
prov
ide
t
he
m
.
T
he
s
e
c
on
ce
rns
slow
or
pr
e
v
e
nt
de
ploym
e
nt
o
f
c
lou
d
AI
i
n
som
e
pr
ac
t
ice
s
(
[10]
www
.
a
m
a
-
a
ssn
.
or
g
).
C
l
i
n
ica
l
V
a
l
idi
ty
a
n
d
L
iabi
l
i
ty
.
M
a
ny
p
h
ys
icia
ns
he
s
i
t
a
t
e
to
r
e
ly
on
“
b
l
ack
-
b
ox
”
AI
f
or
c
l
i
n
ica
l
deci
s
i
ons
.
I
n
pr
i
v
a
t
e
s
e
tt
i
n
g
s
,
t
he
m
a
r
gi
n
f
or
e
rror
i
s
sl
i
m
.
C
on
ce
rns
i
n
c
lu
de
:
“
W
ha
t
if
t
he
AI
m
i
ss
e
s
a
diag
nos
i
s
or
su
gge
sts
a
wron
g
tr
ea
tm
e
nt
?”
a
n
d
“
H
ow
d
o
e
s
t
hi
s
affec
t
my
l
iabi
l
i
ty
if
a
u
di
t
ed
?”
L
ack
o
f
c
l
i
n
ica
l
e
v
ide
n
ce
or
FDA
a
pprov
a
l
f
or
m
a
ny
AI
c
l
ai
ms
ca
us
e
s
s
ke
pt
ici
sm
.
H
igh
-
qu
a
l
i
ty
v
a
l
ida
t
i
on
stu
die
s
a
r
e
o
f
t
e
n
c
on
d
u
c
t
ed
b
y
l
a
r
ge
acade
m
ic
ce
nt
e
rs
,
a
n
d
sm
a
ll
e
r
pr
ac
t
ice
p
h
ys
icia
ns
m
a
y
fi
n
d
i
t
diffic
ult
to
e
v
a
lu
a
t
e
v
e
n
d
or
c
l
ai
ms
i
n
de
p
e
n
de
ntly
.
A
s
on
e
e
xp
e
rt
not
ed
,
d
o
c
tors
w
a
nt
AI
tools
t
ha
t
a
r
e
tr
a
nsp
a
r
e
nt
a
n
d
c
l
i
n
ica
lly
v
a
l
ida
t
ed
(
[41]
www
.
h
n
a
-
n
e
t
.
c
om
).
U
nt
i
l
su
ch
trust
i
s
fi
rmly
e
st
ab
l
i
s
hed
,
m
a
ny
w
i
ll
l
i
m
i
t
AI
us
e
to
low
-
r
i
s
k
t
a
s
k
s
(
e
.
g
.
not
e
-
t
aki
n
g
r
a
t
he
r
t
ha
n
pr
e
s
c
r
ibi
n
g
g
u
ida
n
ce
).
W
or
kf
low
D
i
srupt
i
on
a
n
d
T
r
ai
n
i
n
g
.
I
mpl
e
m
e
nt
i
n
g
AI
o
f
t
e
n
r
e
qu
i
r
e
s
st
aff
tr
ai
n
i
n
g
a
n
d
cha
n
ge
s
i
n
dai
ly
rout
i
n
e
s
.
F
or
e
x
a
mpl
e
,
us
i
n
g
a
n
AI
s
c
r
ibe
m
ea
ns
d
o
c
tors
m
a
y
s
hif
t
f
rom
dic
t
a
t
i
n
g
t
he
ms
e
lv
e
s
to
“
c
onv
e
rs
i
n
g
n
a
tur
a
lly
”
w
i
t
h
a
n
AI
l
i
st
e
n
e
r
,
w
hich
ca
n
fee
l
str
a
n
ge
a
t
fi
rst
.
S
t
aff
m
a
y
a
lso
r
e
s
i
st
if
t
he
y
fea
r
j
o
b
r
e
pl
ace
m
e
nt
.
A
de
qu
a
t
e
tr
ai
n
i
n
g
t
i
m
e
a
n
d
cha
n
ge
m
a
n
age
m
e
nt
a
r
e
n
eeded
,
w
hich
b
usy
pr
ac
t
ice
s
m
a
y
stru
gg
l
e
to
prov
ide
.
I
n
s
h
ort
,
t
he
tr
a
ns
i
t
i
on
c
ost
–
i
n
t
i
m
e
a
n
d
l
ea
rn
i
n
g
c
urv
e
–
ca
n
be
a
hidde
n
ba
rr
ie
r
.
L
ack
o
f
S
t
aff
E
xp
e
rt
i
s
e
.
M
a
ny
sm
a
ll
pr
ac
t
ice
s
ha
v
e
l
i
m
i
t
ed
I
T
or
da
t
a
e
xp
e
rt
i
s
e
.
W
he
n
pro
b
l
e
ms
a
r
i
s
e
(
e
.
g
.
AI
syst
e
m
e
rrors
,
n
eeded
c
ustom
i
z
a
t
i
on
),
t
he
y
ca
n
bec
om
e
debi
l
i
t
a
t
i
n
g
.
L
a
r
ge
r
i
nst
i
tut
i
ons
o
f
t
e
n
ha
v
e
CIO
s
or
i
n
f
orm
a
t
ici
sts
to
m
a
n
age
AI
pro
jec
ts
;
sm
a
ll
o
ffice
s
ge
n
e
r
a
lly
d
o
not
.
S
om
e
AI
v
e
n
d
ors
a
tt
e
mpt
to
fi
ll
t
hi
s
ga
p
(
o
ffe
r
i
n
g
on
b
o
a
r
di
n
g
he
lp
),
b
ut
i
t
r
e
m
ai
ns
a
c
onstr
ai
nt
on
acce
l
e
r
a
t
ed
upt
ake
.
E
t
hica
l
a
n
d
E
qu
i
ty
C
on
ce
rns
.
A
lt
h
ou
gh
o
f
t
e
n
ov
e
rloo
ked
i
n
pr
ac
t
ice
-
l
e
v
e
l
di
s
c
uss
i
ons
,
t
he
r
e
a
r
e
syst
e
m
ic
i
ssu
e
s
.
U
n
checked
,
AI
c
oul
d
w
ide
n
hea
lt
hca
r
e
di
sp
a
r
i
t
ie
s
:
w
ea
lt
h
y
ur
ba
n
c
l
i
n
ic
s
m
a
y
a
ttr
ac
t
t
he
l
a
t
e
st
AI
i
nv
e
stm
e
nts
,
w
hi
l
e
rur
a
l
/
un
de
rs
e
rv
ed
c
l
i
n
ic
s
l
ag
.
I
n
deed
,
a
s
m
e
nt
i
on
ed
,
rur
a
l
h
osp
i
t
a
ls
ha
v
e
m
a
r
ked
ly
low
e
r
AI
us
e
(
[38]
www
.
hea
lt
hi
t
.
g
ov
).
O
n
t
he
e
t
hica
l
s
ide
,
if
AI
a
l
g
or
i
t
h
ms
a
r
e
bia
s
ed
(
f
or
e
x
a
mpl
e
b
y
un
de
rr
e
pr
e
s
e
nt
i
n
g
ce
rt
ai
n
p
a
t
ie
nt
g
roups
i
n
tr
ai
n
i
n
g
da
t
a
),
a
utom
a
t
ed
deci
s
i
ons
m
igh
t
i
n
ad
v
e
rt
e
ntly
r
ed
u
ce
ca
r
e
qu
a
l
i
ty
f
or
som
e
popul
a
t
i
ons
.
P
r
ac
t
ice
s
w
i
ll
n
eed
to
c
ons
ide
r
t
he
s
e
fac
tors
,
e
sp
ecia
lly
i
n
di
v
e
rs
e
c
ommun
i
t
ie
s
.
E
ach
o
f
t
he
s
e
cha
ll
e
n
ge
s
i
s
w
e
ll
-
d
o
c
um
e
nt
ed
.
T
he
AMA
a
n
d
ot
he
r
b
o
die
s
e
mp
ha
s
i
z
e
t
ha
t
f
or
r
e
spons
ib
l
e
AI
ad
opt
i
on
,
pr
ac
t
ice
s
must
i
ns
i
st
on
s
afeg
u
a
r
d
s
:
p
a
t
ie
nt
da
t
a
pr
i
v
ac
y
,
tr
a
nsp
a
r
e
nt
a
l
g
or
i
t
h
ms
,
ov
e
rs
igh
t
pol
icie
s
,
a
n
d
c
l
a
r
i
ty
on
l
iabi
l
i
ty
(
[10]
www
.
a
m
a
-
a
ssn
.
or
g
)
(
[16]
www
.
m
edica
l
ec
onom
ic
s
.
c
om
).
U
nt
i
l
a
n
d
unl
e
ss
t
he
s
e
i
ssu
e
s
a
r
e
add
r
e
ss
ed
,
som
e
pr
i
v
a
t
e
c
l
i
n
icia
ns
w
i
ll
pro
g
r
e
ss
ca
ut
i
ously
.
C
a
s
e
S
tu
die
s
a
n
d
R
ea
l
-
W
orl
d
E
x
a
mpl
e
s
O
ak
M
edica
l
(
W
i
s
c
ons
i
n
M
ult
i
sp
ecia
lty
P
r
ac
t
ice
)
IntuitionLabs - Custom AI Software Development
from the leading AI expert Adrien Laurent AI in Private Practice: 2025 Adoption Trends & Statistics
© 2025 IntuitionLabs.ai - North America's Leading AI Software Development Firm for Pharmaceutical & Biotech. All rights reserved. Page 9 of 17
O
ak
M
edica
l
G
roup
(
a
W
i
s
c
ons
i
n
-
ba
s
ed
pr
i
v
a
t
e
mult
i
sp
ecia
lty
pr
ac
t
ice
w
i
t
h
~90
prov
ide
rs
)
prov
ide
s
a
us
ef
ul
r
ea
l
-
worl
d
i
llustr
a
t
i
on
.
A
cc
or
di
n
g
to
AMA
r
e
port
i
n
g
,
O
ak
did
not
ha
v
e
t
he
ca
p
i
t
a
l
to
ad
opt
a
big
h
osp
i
t
a
l
EHR
(
E
p
ic
/
C
e
rn
e
r
)
t
ha
t
o
f
t
e
n
c
om
e
s
w
i
t
h
AI
fea
tur
e
s
.
I
nst
ead
,
t
he
pr
ac
t
ice
i
ts
e
l
f
ide
nt
ified
a
n
d
de
ploy
ed
AI
tools
to
b
oost
efficie
n
c
y
(
[47]
www
.
a
m
a
-
a
ssn
.
or
g
)
(
[48]
www
.
a
m
a
-
a
ssn
.
or
g
).
F
or
i
nst
a
n
ce
,
O
ak
us
e
s
AI
f
or
s
ched
ul
i
n
g
a
utom
a
t
i
on
:
on
ce
a
p
a
t
ie
nt
i
s
ad
m
i
tt
ed
to
on
e
o
f
t
hei
r
post
-
ac
ut
e
faci
l
i
t
ie
s
,
a
n
a
l
g
or
i
t
h
m
a
utom
a
t
ica
lly
s
ched
ul
e
s
f
ollow
-
up
a
ppo
i
ntm
e
nts
(
[48]
www
.
a
m
a
-
a
ssn
.
or
g
).
T
he
y
a
lso
us
e
AI
to
pro
ce
ss
i
n
c
om
i
n
g
fa
x
e
s
a
n
d
ha
n
d
l
e
bi
ll
i
n
g
/
ad
m
i
n
t
a
s
k
s
.
T
hei
r
AI
tools
ge
n
e
r
a
t
e
v
i
s
i
t
not
e
s
b
y
pull
i
n
g
r
e
l
e
v
a
nt
i
n
f
orm
a
t
i
on
f
rom
p
a
t
ie
nt
r
ec
or
d
s
a
n
d
dic
t
a
t
i
on
(
[48]
www
.
a
m
a
-
a
ssn
.
or
g
).
D
r
.
K
e
s
h
n
i
R
a
mn
a
n
a
n
(
O
ak
ʼ
s
CMO
)
r
e
ports
t
ha
t
t
he
s
e
tools
ha
v
e
m
ea
sur
ab
ly
i
mprov
ed
wor
kf
low
,
f
r
eei
n
g
st
aff
to
f
o
c
us
on
ca
r
e
r
a
t
he
r
t
ha
n
p
a
p
e
rwor
k
.
N
ot
ab
ly
,
O
ak
M
edica
l
ʼ
s
e
xp
e
r
ie
n
ce
un
de
rs
c
or
e
s
two
t
he
m
e
s
:
(1)
e
v
e
n
sm
a
ll
g
roups
ca
n
t
ai
lor
AI
tools
to
t
hei
r
n
eed
s
,
e
sp
ecia
lly
f
or
rout
i
n
e
“
back
-
o
ffice
”
f
un
c
t
i
ons
(
[48]
www
.
a
m
a
-
a
ssn
.
or
g
),
a
n
d
(2)
ad
opt
i
on
w
a
s
d
r
i
v
e
n
b
ottom
-
up
b
y
c
l
i
n
icia
ns
s
eeki
n
g
r
e
l
ief
,
not
top
-
d
own
m
a
n
da
t
e
s
.
O
ak
ʼ
s
a
ppro
ach
–
solv
i
n
g
t
hei
r
most
t
i
m
e
-
c
onsum
i
n
g
t
a
s
k
s
fi
rst
–
e
x
e
mpl
ifie
s
t
he
pr
ag
m
a
t
ic
“
st
a
rt
sm
a
ll
a
n
d
s
ca
l
e
”
str
a
t
eg
y
r
ec
omm
e
n
ded
f
or
pr
i
v
a
t
e
pr
ac
t
ice
s
(
[42]
www
.
h
n
a
-
n
e
t
.
c
om
).
C
l
e
v
e
l
a
n
d
C
l
i
n
ic
B
a
y
e
s
ia
n
S
e
ps
i
s
A
l
e
rt
A
lt
h
ou
gh
a
l
a
r
ge
acade
m
ic
n
e
twor
k
r
a
t
he
r
t
ha
n
a
pr
i
v
a
t
e
pr
ac
t
ice
,
C
l
e
v
e
l
a
n
d
C
l
i
n
ic
ʼ
s
s
e
ps
i
s
a
l
e
rt
i
llustr
a
t
e
s
AI
ʼ
s
high
-
e
n
d
c
l
i
n
ica
l
pot
e
nt
ia
l
.
I
n
2025,
C
l
e
v
e
l
a
n
d
C
l
i
n
ic
roll
ed
out
a
n
AI
a
l
g
or
i
t
h
m
(
B
a
y
e
s
ia
n
H
ea
lt
h
pl
a
t
f
orm
)
ac
ross
13
h
osp
i
t
a
ls
to
ide
nt
if
y
s
e
ps
i
s
ea
rly
(
[23]
n
e
wsroom
.
c
l
e
v
e
l
a
n
dc
l
i
n
ic
.
or
g
).
I
n
a
pu
b
l
i
s
hed
pr
e
ss
r
e
port
,
t
he
y
r
e
port
ed
d
r
a
m
a
t
ic
i
mprov
e
m
e
nts
:
a
t
e
n
-
f
o
ld
r
ed
u
c
t
i
on
i
n
fa
ls
e
a
l
e
rts
(
a
mon
g
t
h
os
e
s
c
r
ee
n
ed
),
a
46
%
i
n
c
r
ea
s
e
i
n
ide
nt
ified
s
e
ps
i
s
ca
s
e
s
,
a
n
d
a
s
e
v
e
n
-
f
o
ld
r
i
s
e
i
n
a
l
e
rts
s
e
nt
bef
or
e
a
nt
ibi
ot
ic
ad
m
i
n
i
str
a
t
i
on
(
[26]
n
e
wsroom
.
c
l
e
v
e
l
a
n
dc
l
i
n
ic
.
or
g
).
T
hi
s
m
ea
ns
m
a
ny
p
a
t
ie
nts
w
e
r
e
tr
ea
t
ed
mu
ch
soon
e
r
,
l
ike
ly
s
a
v
i
n
g
l
i
v
e
s
.
K
e
y
l
e
ssons
f
or
pr
i
v
a
t
e
pr
ac
t
ice
s
:
AI
ca
n
prov
ide
v
a
lu
e
b
y
ca
t
chi
n
g
da
n
ge
rous
c
on
di
t
i
ons
fa
st
e
r
,
b
ut
achie
v
i
n
g
su
ch
be
n
efi
ts
r
e
qu
i
r
ed
i
nt
eg
r
a
t
i
on
i
nto
t
he
c
l
i
n
ica
l
wor
kf
low
a
n
d
a
l
a
r
ge
s
ca
l
e
o
f
da
t
a
.
S
m
a
ll
e
r
pr
ac
t
ice
s
s
h
oul
d
not
e
t
he
gai
ns
(
mor
e
acc
ur
a
t
e
tr
iage
,
l
e
ss
a
l
e
rt
fa
t
ig
u
e
f
or
tru
e
ca
s
e
s
)
b
ut
a
lso
t
he
c
ompl
e
x
i
ty
a
n
d
n
eed
f
or
i
nt
eg
r
a
t
i
on
i
nto
p
a
t
ie
nt
m
a
n
age
m
e
nt
syst
e
ms
.
A
t
he
n
ahea
lt
h
ʼ
s
AI
-
N
a
t
i
v
e
EHR
I
n
A
u
g
ust
2025,
A
t
he
n
ahea
lt
h
a
nnoun
ced
a
m
aj
or
pl
a
t
f
orm
up
g
r
ade
to
a
n
“
AI
-
n
a
t
i
v
e
”
a
t
he
n
a
O
n
e
EHR
(
[13]
www
.
fie
r
cehea
lt
hca
r
e
.
c
om
).
A
t
he
n
ahea
lt
h
ʼ
s
c
ustom
e
r
ba
s
e
i
s
pr
i
m
a
r
i
ly
i
n
de
p
e
n
de
nt
d
o
c
s
a
n
d
sm
a
ll
g
roups
.
T
he
y
w
i
ll
de
ploy
n
e
w
AI
fea
tur
e
s
f
or
a
ll
(160,000+)
pr
ac
t
ice
e
n
d
po
i
nts
s
i
mult
a
n
e
ously
(
[49]
www
.
fie
r
cehea
lt
hca
r
e
.
c
om
).
T
he
s
e
i
n
c
lu
de
AI
-
e
n
ha
n
ced
d
o
c
um
e
nt
s
e
rv
ice
s
(
a
uto
-
c
ompl
e
t
e
not
e
s
),
i
mprov
ed
i
nt
e
rop
e
r
abi
l
i
ty
tools
(
sm
a
rt
tr
a
nsl
a
t
i
on
o
f
e
xt
e
rn
a
l
r
ec
or
d
s
),
a
n
d
i
nt
e
ll
ige
nt
c
l
i
n
ica
l
summ
a
r
ie
s
(
e
.
g
.
AI
-
d
r
af
t
ed
ca
r
e
pl
a
ns
).
A
t
he
n
ahea
lt
h
ʼ
s
a
ppro
ach
high
l
igh
ts
h
ow
EHR
v
e
n
d
ors
a
r
e
ac
t
i
v
e
ly
pus
hi
n
g
AI
i
nto
pr
i
v
a
t
e
pr
ac
t
ice
cha
nn
e
ls
.
F
or
a
n
i
n
di
v
id
u
a
l
pr
ac
t
ice
,
t
hi
s
m
ea
ns
t
ha
t
tomorrow
ʼ
s
EHR
up
da
t
e
m
a
y
b
r
i
n
g
n
e
w
AI
ca
p
abi
l
i
t
ie
s
“
a
utom
agica
lly
,”
low
e
r
i
n
g
t
he
i
nt
eg
r
a
t
i
on
b
ur
de
n
.
I
t
a
lso
m
ea
ns
sm
a
ll
pr
ac
t
ice
s
ca
n
gai
n
acce
ss
to
ad
v
a
n
ced
fea
tur
e
s
t
h
rou
gh
t
hei
r
v
e
n
d
or
r
e
l
a
t
i
ons
hi
ps
,
r
a
t
he
r
t
ha
n
pro
c
ur
i
n
g
st
a
n
da
lon
e
syst
e
ms
.
R
e
s
ea
r
ch
S
tu
d
y
:
U
K G
e
n
e
r
a
l
P
r
ac
t
ice
s
A
p
ee
r
-
r
e
v
ie
w
ed
U
K
stu
d
y
(
D
igi
t
H
ea
lt
h
,
N
ov
2025)
surv
e
y
ed
1005
U
K
ge
n
e
r
a
l
pr
ac
t
i
t
i
on
e
rs
on
ge
n
e
r
a
t
i
v
e
AI
us
e
(
[21]
pm
c
.
n
cbi
.
nlm
.
n
ih
.
g
ov
).
I
t
f
oun
d
25
%
had
a
lr
ead
y
tr
ied
G
e
n
AI
cha
t
b
ots
or
a
ss
i
st
a
nts
i
n
pr
ac
t
ice
.
O
f
t
h
os
e
us
e
rs
,
c
ommon
t
a
s
k
s
i
n
c
lu
ded
ge
n
e
r
a
t
i
n
g
d
o
c
um
e
nt
a
t
i
on
af
t
e
r
a
ppo
i
ntm
e
nts
(35
%
o
f
G
e
n
AI
us
e
rs
),
su
gge
st
i
n
g
diffe
r
e
nt
ia
l
diag
nos
e
s
(27
%
),
a
n
d
ge
n
e
r
a
t
i
n
g
tr
ea
tm
e
nt
or
r
efe
rr
a
l
su
gge
st
i
ons
(24
%
each
)
(
[21]
pm
c
.
n
cbi
.
nlm
.
n
ih
.
g
ov
).
N
ot
ab
ly
,
71
%
o
f
t
he
G
e
n
AI
us
e
rs
s
aid
t
he
tools
r
ed
u
ced
t
hei
r
wor
k
lo
ad
.
T
hi
s
i
s
on
e
o
f
t
he
fi
rst
l
a
r
ge
-
s
a
mpl
e
surv
e
ys
g
lo
ba
lly
s
h
ow
i
n
g
t
ha
t
e
v
e
n
“
o
ffice
-
ba
s
ed
”
d
o
c
tors
a
r
e
e
xp
e
r
i
m
e
nt
i
n
g
w
i
t
h
ad
v
a
n
ced
AI
.
T
he
ca
ut
i
on
a
ry
p
a
rt
i
s
t
ha
t
75
%
o
f
d
o
c
tors
not
us
i
n
g
G
e
n
AI
had
n
e
v
e
r
e
v
e
n
tr
ied
i
t
(
t
h
ou
gh
79
%
o
f
a
ll
d
o
c
tors
i
n
t
he
l
a
r
ge
r
AMA
surv
e
y
e
xpr
e
ss
ed
som
e
trust
i
n
AI
ʼ
s
pot
e
nt
ia
l
(
[12]
www
.
ic
t
hea
lt
h
.
or
g
)).
F
or
pr
i
v
a
t
e
U
.
S
.
IntuitionLabs - Custom AI Software Development
from the leading AI expert Adrien Laurent AI in Private Practice: 2025 Adoption Trends & Statistics
© 2025 IntuitionLabs.ai - North America's Leading AI Software Development Firm for Pharmaceutical & Biotech. All rights reserved. Page 10 of 17
pr
ac
t
ice
s
,
t
hi
s
su
gge
sts
a
c
omp
a
r
ab
l
e
ea
rly
-
ad
opt
e
r
s
eg
m
e
nt
(
p
e
r
ha
ps
a
qu
a
rt
e
r
o
f
pr
ac
t
ice
s
)
i
s
a
lr
ead
y
us
i
n
g
ge
n
e
r
a
t
i
v
e
AI
i
n
som
e
fa
s
hi
on
,
mostly
f
or
d
o
c
um
e
nt
a
t
i
on
a
n
d
deci
s
i
on
support
.
T
he
s
e
ca
s
e
stu
die
s
i
llustr
a
t
e
t
ha
t
w
he
n
a
ppropr
ia
t
e
AI
tools
a
r
e
i
mpl
e
m
e
nt
ed
,
pr
i
v
a
t
e
pr
ac
t
ice
s
ca
n
r
ea
p
s
ig
n
ifica
nt
be
n
efi
ts
.
T
he
y
a
lso
i
llustr
a
t
e
c
ommon
t
he
m
e
s
:
st
a
rt
w
i
t
h
t
he
highe
st
-
p
a
yo
ff
t
a
s
k
s
(
not
e
s
,
s
ched
ul
i
n
g
),
e
nsur
e
tools
fi
t
t
he
wor
kf
low
,
a
n
d
i
nvolv
e
c
l
i
n
icia
ns
i
n
s
e
l
ec
t
i
n
g
a
n
d
mon
i
tor
i
n
g
t
he
AI
.
I
mpl
ica
t
i
ons
,
F
utur
e
D
i
r
ec
t
i
ons
,
a
n
d
R
ec
omm
e
n
da
t
i
ons
I
mpl
ica
t
i
ons
f
or
C
a
r
e
D
e
l
i
v
e
ry
T
he
spr
eadi
n
g
us
e
o
f
AI
i
n
pr
i
v
a
t
e
pr
ac
t
ice
s
w
i
ll
ha
v
e
b
ro
ad
i
mpl
ica
t
i
ons
:
W
or
kf
low
T
r
a
ns
f
orm
a
t
i
on
.
A
nt
ici
p
a
t
e
c
ont
i
nu
ed
a
utom
a
t
i
on
o
f
mun
da
n
e
t
a
s
k
s
:
b
y
2026–27,
i
t
i
s
pl
a
us
ib
l
e
t
ha
t
a
lmost
a
ll
s
ched
ul
i
n
g
,
r
e
m
i
n
de
rs
,
a
n
d
p
a
p
e
rwor
k
ge
n
e
r
a
t
i
on
c
oul
d
be
ha
n
d
l
ed
b
y
AI
tools
i
n
f
orw
a
r
d
-
loo
ki
n
g
pr
ac
t
ice
s
.
T
hi
s
woul
d
f
r
ee
up
m
edica
l
a
ss
i
st
a
nts
a
n
d
nurs
e
s
f
or
highe
r
-
v
a
lu
e
t
a
s
k
s
(
p
a
t
ie
nt
ed
u
ca
t
i
on
,
f
ollow
-
ups
)
a
n
d
a
llow
d
o
c
tors
mor
e
face
-
to
-
face
t
i
m
e
.
A
r
ece
nt
P
hi
l
i
ps
r
e
port
su
gge
sts
up
to
$
200–
$
360
bi
ll
i
on
i
n
U
.
S
.
hea
lt
hca
r
e
sp
e
n
di
n
g
c
ou
ld
be
s
a
v
ed
n
a
t
i
on
a
lly
t
h
rou
gh
w
ide
spr
ead
AI
,
m
ai
nly
b
y
str
ea
ml
i
n
i
n
g
pro
ce
ss
e
s
a
n
d
r
ed
u
ci
n
g
unn
ece
ss
a
ry
pro
ced
ur
e
s
(
[50]
www
.
ic
t
hea
lt
h
.
or
g
).
S
hif
t
i
n
S
ki
lls
a
n
d
R
ol
e
s
.
C
l
i
n
icia
ns
w
i
ll
n
eed
n
e
w
s
ki
lls
i
n
“
AI
l
i
t
e
r
ac
y
”:
un
de
rst
a
n
di
n
g
t
he
l
i
m
i
ts
o
f
tools
,
i
nt
e
rpr
e
t
i
n
g
AI
su
gge
st
i
ons
,
a
n
d
c
ommun
ica
t
i
n
g
w
i
t
h
AI
-
a
ss
i
st
ed
syst
e
ms
.
M
edica
l
tr
ai
n
i
n
g
(
R
e
s
ide
n
c
y
a
n
d
CME
)
i
s
begi
nn
i
n
g
to
i
n
c
orpor
a
t
e
AI
top
ic
s
.
P
r
ac
t
ice
s
m
a
y
s
ee
rol
e
s
l
ike
‘
AI
c
oor
di
n
a
tor
ʼ
or
a
c
onsult
a
rr
a
n
ge
m
e
nt
w
i
t
h
i
n
f
orm
a
t
ic
s
e
xp
e
rts
.
R
ed
u
c
t
i
ons
i
n
ad
m
i
n
i
str
a
t
i
v
e
wor
k
lo
ad
m
igh
t
o
ff
s
e
t
som
e
b
urnout
,
b
ut
som
e
worry
t
ha
t
n
e
w
t
a
s
k
s
(
mon
i
tor
i
n
g
AI
,
v
e
r
if
y
i
n
g
outputs
)
w
i
ll
a
r
i
s
e
.
P
a
t
ie
nt
E
xp
e
r
ie
n
ce
C
ha
n
ge
s
.
W
i
t
h
AI
s
ched
ul
i
n
g
a
n
d
cha
t
b
ots
,
p
a
t
ie
nts
w
i
ll
e
n
j
oy
24/7
c
onv
e
n
ie
n
ce
(
e
v
e
n
i
n
g
s
/
w
eeke
n
d
b
oo
ki
n
g
s
).
C
onv
e
rs
e
ly
,
p
a
t
ie
nts
w
i
ll
i
nt
e
r
ac
t
mor
e
o
f
t
e
n
w
i
t
h
a
l
g
or
i
t
h
ms
(
e
.
g
.
a
nsw
e
r
i
n
g
rout
i
n
e
qu
e
st
i
ons
v
ia
cha
t
b
ot
).
T
rust
bec
om
e
s
ke
y
:
a
s
not
ed
,
p
a
t
ie
nts
acce
pt
AI
f
or
a
ppo
i
ntm
e
nts
b
ut
a
r
e
w
a
ry
o
f
AI
m
aki
n
g
c
l
i
n
ica
l
j
u
dg
m
e
nts
(
[12]
www
.
ic
t
hea
lt
h
.
or
g
).
P
r
ac
t
ice
s
must
tr
a
nsp
a
r
e
ntly
c
ommun
ica
t
e
h
ow
t
he
y
us
e
AI
,
a
n
d
e
nsur
e
h
um
a
n
ov
e
rs
igh
t
,
to
m
ai
nt
ai
n
p
a
t
ie
nt
trust
.
Q
u
a
l
i
ty
a
n
d
E
qu
i
ty
.
I
f
prop
e
rly
v
a
l
ida
t
ed
,
AI
ha
s
t
he
pot
e
nt
ia
l
to
i
mprov
e
diag
nos
i
s
a
n
d
out
c
om
e
s
.
F
or
e
x
a
mpl
e
,
a
utom
a
t
ed
s
c
r
ee
n
i
n
g
tools
(
l
ike
D
iabe
t
ic
r
e
t
i
nop
a
t
h
y
de
t
ec
t
i
on
)
ca
n
he
lp
e
nsur
e
no
p
a
t
ie
nt
sl
i
ps
t
h
rou
gh
.
H
ow
e
v
e
r
,
t
he
r
e
i
s
a
lso
r
i
s
k
:
if
sm
a
ll
e
r
pr
ac
t
ice
s
ca
nnot
i
mpl
e
m
e
nt
AI
,
t
he
y
m
a
y
l
ag
i
n
qu
a
l
i
ty
.
T
he
r
e
i
s
a
n
e
qu
i
ty
c
on
ce
rn
if
only
aff
lu
e
nt
pr
ac
t
ice
s
be
n
efi
t
.
P
ol
ic
ym
ake
rs
a
n
d
pro
fe
ss
i
on
a
l
so
cie
t
ie
s
w
i
ll
n
eed
to
add
r
e
ss
t
hi
s
“
digi
t
a
l
di
v
ide
”
(
f
or
i
nst
a
n
ce
,
b
y
su
b
s
idi
z
i
n
g
AI
i
n
un
de
rs
e
rv
ed
a
r
ea
s
or
i
n
c
lu
di
n
g
AI
-
r
eadi
n
e
ss
i
n
qu
a
l
i
ty
m
e
tr
ic
s
).
E
m
e
r
gi
n
g
T
r
e
n
d
s
L
oo
ki
n
g
ahead
t
h
rou
gh
2026–2030,
s
e
v
e
r
a
l
tr
e
n
d
s
a
r
e
on
t
he
h
or
i
zon
:
G
e
n
e
r
a
t
i
v
e
AI I
nt
eg
r
a
t
i
on
.
L
a
r
ge
l
a
n
g
u
age
mo
de
ls
(
LLM
s
)
a
r
e
i
mprov
i
n
g
r
a
p
id
ly
.
E
xp
ec
t
to
s
ee
i
nt
eg
r
a
t
i
on
o
f
ge
n
e
r
a
t
i
v
e
AI
i
nto
EHR
s
a
n
d
pr
ac
t
ice
a
pps
:
e
.
g
.
on
e
-
c
l
ick
GP
summ
a
r
ie
s
o
f
p
a
t
ie
nt
hi
story
,
AI
d
r
af
t
i
n
g
o
f
r
efe
rr
a
l
l
e
tt
e
rs
,
or
c
onv
e
rs
a
t
i
on
a
l
Q
&
A
tools
f
or
p
a
t
ie
nt
tr
iage
.
D
e
lo
i
tt
e
ʼ
s
2024
L
ife
S
cie
n
ce
s
surv
e
y
f
oun
d
92
%
o
f
l
eade
rs
s
ee
efficie
n
c
y
prom
i
s
e
i
n
G
e
n
AI
(
[14]
www
.
de
lo
i
tt
e
.
c
om
),
a
n
d
75
%
a
r
e
a
lr
ead
y
s
ca
l
i
n
g
i
t
.
F
or
pr
i
v
a
t
e
pr
ac
t
ice
s
,
acce
ss
ib
l
e
G
e
n
AI
c
oul
d
de
mo
c
r
a
t
i
z
e
som
e
ad
v
a
n
ced
a
n
a
lys
e
s
(
a
solo
d
o
c
w
i
t
h
a
GP
T
-
ba
s
ed
a
ss
i
st
a
nt
m
a
y
d
r
af
t
r
e
s
ea
r
ch
propos
a
ls
or
c
ompl
e
x
ca
r
e
summ
a
r
ie
s
).
AI
-
A
ss
i
st
ed
V
i
rtu
a
l
C
a
r
e
.
H
y
b
r
id
ca
r
e
mo
de
ls
(
c
om
bi
n
i
n
g
bi
rtu
a
l
a
n
d
i
n
-
p
e
rson
)
w
i
ll
us
e
AI
mor
e
.
F
or
e
x
a
mpl
e
,
i
n
i
t
ia
l
tr
iage
t
h
rou
gh
a
n
AI
ca
n
de
t
e
rm
i
n
e
w
he
t
he
r
a
p
a
t
ie
nt
n
eed
s
a
n
i
n
-
o
ffice
v
i
s
i
t
,
l
ab
t
e
st
,
or
if
a
d
o
c
tor
ʼ
s
t
e
l
ec
onsult
su
ffice
s
.
AI
tools
w
i
ll
l
i
n
k
mor
e
m
edica
l
de
v
ice
s
(
w
ea
r
ab
l
e
s
,
h
om
e
mon
i
tors
)
i
nto
t
he
pr
ac
t
ice
ʼ
s
da
t
a
str
ea
m
,
f
l
aggi
n
g
s
ig
n
ifica
nt
cha
n
ge
s
(
e
.
g
.).
W
i
t
h
r
e
mot
e
mon
i
tor
i
n
g
r
ei
m
b
urs
ab
l
e
b
y
CMS
,
pr
i
v
a
t
e
pr
ac
t
ice
s
m
igh
t
l
e
v
e
r
age
AI
a
n
a
lyt
ic
s
on
p
a
t
ie
nt
-
ge
n
e
r
a
t
ed
da
t
a
(
e
.
g
.
h
om
e
b
loo
d
pr
e
ssur
e
tr
e
n
d
s
).
IntuitionLabs - Custom AI Software Development
from the leading AI expert Adrien Laurent AI in Private Practice: 2025 Adoption Trends & Statistics
© 2025 IntuitionLabs.ai - North America's Leading AI Software Development Firm for Pharmaceutical & Biotech. All rights reserved. Page 11 of 17
S
t
a
n
da
r
d
-
o
f
-
C
a
r
e
E
xp
ec
t
a
t
i
ons
.
A
ke
y
fi
n
di
n
g
i
n
t
he
AMA
ʼ
s
a
n
a
lys
i
s
w
a
s
t
ha
t
57
%
o
f
pr
i
v
a
t
e
p
h
ys
icia
ns
a
lr
ead
y
c
ons
ide
r
AI
to
be
(
or
soon
-
to
-
be
)
“
t
he
st
a
n
da
r
d
o
f
ca
r
e
”
(
[44]
www
.
a
m
a
-
a
ssn
.
or
g
).
I
n
ce
rt
ai
n
sp
ecia
lt
ie
s
(
r
adi
olo
g
y
,
ca
r
di
olo
g
y
),
fai
l
i
n
g
to
us
e
st
a
n
da
r
d
AI
tools
m
a
y
r
ai
s
e
m
a
lpr
ac
t
ice
qu
e
st
i
ons
(
e
.
g
.
“
W
h
y
w
a
sn
ʼ
t
t
hi
s
a
l
g
or
i
t
h
m
us
ed
to
ca
t
ch
t
ha
t
fi
n
di
n
g
?”
(
[44]
www
.
a
m
a
-
a
ssn
.
or
g
)).
O
v
e
r
t
i
m
e
,
i
t
i
s
l
ike
ly
t
ha
t
g
u
ide
l
i
n
e
s
w
i
ll
e
volv
e
to
i
n
c
orpor
a
t
e
AI
r
ec
omm
e
n
da
t
i
ons
w
he
r
e
e
v
ide
n
ce
i
s
stron
g
,
m
ea
n
i
n
g
pr
i
v
a
t
e
pr
ac
t
ice
s
w
i
ll
n
eed
to
ad
opt
to
m
ee
t
ca
r
e
st
a
n
da
r
d
s
.
E
xp
a
n
ded
T
e
l
ehea
lt
h
a
n
d
C
onsum
e
r
P
l
a
t
f
orms
.
P
r
i
v
a
t
e
pr
ac
t
ice
s
i
n
c
r
ea
s
i
n
g
ly
c
omp
e
t
e
w
i
t
h
t
e
l
ehea
lt
h
st
a
rtups
a
n
d
r
e
t
ai
l
c
l
i
n
ic
s
t
ha
t
hea
v
i
ly
us
e
AI
(
e
.
g
.
symptom
checke
rs
,
f
ully
a
utom
a
t
ed
t
e
l
e
-
c
onsults
).
T
o
st
a
y
r
e
l
e
v
a
nt
,
pr
i
v
a
t
e
c
l
i
n
icia
ns
m
a
y
i
nt
eg
r
a
t
e
s
i
m
i
l
a
r
tools
(
or
p
a
rtn
e
r
w
i
t
h
t
h
os
e
c
omp
a
n
ie
s
).
F
or
e
x
a
mpl
e
,
a
n
AI
-
pow
e
r
ed
tr
iage
cha
t
b
ot
on
a
c
l
i
n
ic
ʼ
s
w
eb
s
i
t
e
c
oul
d
b
oo
k
p
a
t
ie
nts
di
r
ec
tly
,
m
i
m
icki
n
g
l
a
r
ge
t
e
l
ehea
lt
h
s
e
rv
ice
s
.
R
eg
ul
a
tory
O
v
e
rs
igh
t
.
B
eca
us
e
FDA
-
c
l
ea
r
ed
AI
tools
a
r
e
g
row
i
n
g
r
a
p
id
ly
(
ov
e
r
1000
a
s
o
f
2025
(
[16]
www
.
m
edica
l
ec
onom
ic
s
.
c
om
))
a
n
d
st
a
t
e
l
egi
sl
a
tur
e
s
a
r
e
c
ons
ide
r
i
n
g
l
a
ws
,
w
e
ca
n
e
xp
ec
t
n
e
w
r
eg
ul
a
t
i
ons
on
hea
lt
hca
r
e
AI
.
P
r
ac
t
ice
s
w
i
ll
n
eed
to
tr
ack
c
ompl
ia
n
ce
(
e
.
g
.
w
i
t
h
HIPAA
-
l
ike
rul
e
s
f
or
AI
,
or
us
e
o
f
n
a
t
i
on
a
lly
ce
rt
ified
a
l
g
or
i
t
h
ms
).
O
n
t
he
pos
i
t
i
v
e
s
ide
,
g
u
ide
l
i
n
e
s
f
rom
AMA
a
n
d
ot
he
rs
(
i
n
c
lu
di
n
g
g
ov
e
rn
a
n
ce
tool
ki
ts
(
[51]
www
.
a
m
a
-
a
ssn
.
or
g
))
s
h
oul
d
he
lp
d
o
c
tors
ad
opt
r
e
spons
ib
ly
.
P
r
ac
t
ice
s
s
h
oul
d
pr
e
p
a
r
e
b
y
e
st
ab
l
i
s
hi
n
g
c
l
ea
r
“
g
ov
e
rn
a
n
ce
”
ov
e
r
a
ny
AI
us
e
(
a
s
r
ec
omm
e
n
ded
b
y
AMA
S
T
EPS F
orw
a
r
d
tool
ki
t
).
R
ec
omm
e
n
da
t
i
ons
f
or
P
r
i
v
a
t
e
P
r
ac
t
ice
s
1.
S
t
a
rt
w
i
t
h
H
igh
-
V
a
lu
e
,
L
ow
-
R
i
s
k
U
s
e
C
a
s
e
s
.
F
o
c
us
fi
rst
on
t
a
s
k
s
w
i
t
h
c
l
ea
r
ROI
a
n
d
low
c
l
i
n
ica
l
r
i
s
k
–
e
.
g
.,
d
o
c
um
e
nt
a
t
i
on
,
bi
ll
i
n
g
,
p
a
t
ie
nt
r
e
m
i
n
de
rs
.
T
he
AMA
a
n
d
ot
he
rs
r
ec
omm
e
n
d
p
i
lots
i
n
t
he
s
e
a
r
ea
s
(
[42]
www
.
h
n
a
-
n
e
t
.
c
om
).
2.
E
n
gage
S
t
aff
a
n
d
S
t
akeh
ol
de
rs
E
a
rly
.
I
nvolv
e
p
h
ys
icia
ns
,
nurs
e
s
,
a
n
d
e
v
e
n
p
a
t
ie
nts
i
n
s
e
l
ec
t
i
n
g
a
n
d
t
e
st
i
n
g
AI
tools
.
O
b
t
ai
n
t
h
orou
gh
de
mos
a
n
d
tr
ia
l
p
e
r
i
o
d
s
.
E
nsur
e
a
feedback
loop
so
us
e
rs
ca
n
r
e
port
i
ssu
e
s
.
3.
V
a
l
ida
t
e
a
n
d
M
on
i
tor
O
ut
c
om
e
s
.
C
h
oos
e
AI
solut
i
ons
w
i
t
h
pu
b
l
i
s
hed
v
a
l
ida
t
i
on
,
a
n
d
mon
i
tor
r
ea
l
-
worl
d
p
e
r
f
orm
a
n
ce
.
F
or
e
x
a
mpl
e
,
a
u
di
t
a
s
a
mpl
e
o
f
AI
-
ge
n
e
r
a
t
ed
not
e
s
f
or
acc
ur
ac
y
,
or
tr
ack
h
ow
m
a
ny
c
o
di
n
g
su
gge
st
i
ons
a
r
e
acce
pt
ed
.
I
mpl
e
m
e
nt
ov
e
rs
igh
t
pro
ce
ss
e
s
a
s
r
ec
omm
e
n
ded
b
y
pro
fe
ss
i
on
a
l
g
u
ide
l
i
n
e
s
(
[10]
www
.
a
m
a
-
a
ssn
.
or
g
)
(
[16]
www
.
m
edica
l
ec
onom
ic
s
.
c
om
).
4.
P
l
a
n
F
i
n
a
n
cia
lly
.
P
e
r
f
orm
a
ba
s
ic
ROI
a
n
a
lys
i
s
.
E
v
e
n
if
i
mm
edia
t
e
ROI
i
s
un
c
l
ea
r
,
c
ons
ide
r
c
ost
s
a
v
i
n
g
s
(
st
aff
h
ours
,
fe
w
e
r
X
-
r
a
y
r
e
p
ea
ts
,
e
t
c
.)
a
n
d
r
e
v
e
nu
e
gai
ns
(
mor
e
v
i
s
i
ts
poss
ib
l
e
).
L
oo
k
f
or
g
r
a
nts
or
g
roup
pur
cha
s
i
n
g
c
oop
e
r
a
t
i
v
e
s
to
o
ff
s
e
t
c
osts
(
som
e
st
a
t
e
pro
g
r
a
ms
m
a
y
he
lp
rur
a
l
c
l
i
n
ic
s
).
5.
E
nsur
e
D
a
t
a
P
r
i
v
ac
y
a
n
d
S
ec
ur
i
ty
.
O
nly
wor
k
w
i
t
h
v
e
n
d
ors
t
ha
t
o
ffe
r
HIPAA
-
c
ompl
ia
nt
solut
i
ons
a
n
d
a
r
e
w
i
ll
i
n
g
to
s
ig
n
a
B
us
i
n
e
ss
A
sso
cia
t
e
A
g
r
ee
m
e
nt
.
K
ee
p
s
e
ns
i
t
i
v
e
da
t
a
e
n
c
rypt
ed
a
n
d
us
e
on
-
pr
e
m
i
s
e
s
or
v
e
r
ified
c
lou
d
s
e
rv
ice
s
.
P
a
t
ie
nts
s
h
oul
d
be
i
n
f
orm
ed
(
c
ons
e
nt
)
if
AI
i
s
us
ed
i
n
t
hei
r
ca
r
e
.
6.
S
t
a
y
I
n
f
orm
ed
a
n
d
F
l
e
x
ib
l
e
.
T
he
fie
l
d
i
s
e
volv
i
n
g
.
A
tt
e
n
d
r
e
l
e
v
a
nt
c
on
fe
r
e
n
ce
s
(
MGMA
,
AMA
digi
t
a
l
hea
lt
h
summ
i
ts
)
a
n
d
f
ollow
up
da
t
e
s
f
rom
pro
fe
ss
i
on
a
l
a
sso
cia
t
i
ons
.
C
ons
ide
r
j
o
i
n
i
n
g
c
oll
ab
or
a
t
i
v
e
n
e
twor
k
s
(
e
.
g
.
MGMA
,
AAFP AI
di
s
c
uss
i
on
f
orums
)
to
s
ha
r
e
l
e
ssons
.
7.
A
d
vo
ca
t
e
a
t
P
ol
ic
y
L
e
v
e
l
.
G
i
v
e
n
t
he
ad
opt
i
on
ga
p
,
pr
i
v
a
t
e
pr
ac
t
ice
g
roups
s
h
oul
d
ad
vo
ca
t
e
f
or
i
n
ce
nt
i
v
e
s
(
e
.
g
.
g
r
a
nts
f
or
rur
a
l
c
l
i
n
ic
s
),
c
l
ea
r
r
eg
ul
a
t
i
ons
,
a
n
d
i
n
d
ustry
st
a
n
da
r
d
s
.
C
oll
ab
or
a
t
i
on
w
i
t
h
st
a
t
e
m
edica
l
so
cie
t
ie
s
a
n
d
t
he
AMA
ʼ
s
AI
i
n
i
t
ia
t
i
v
e
s
ca
n
he
lp
s
ha
p
e
support
i
v
e
pol
ic
y
(
su
ch
a
s
r
ei
m
b
urs
e
m
e
nt
f
or
AI
-
a
ss
i
st
ed
s
e
rv
ice
s
or
f
un
di
n
g
f
or
EHR
i
nt
eg
r
a
t
i
on
support
).
B
y
t
aki
n
g
a
pro
ac
t
i
v
e
,
i
n
f
orm
ed
a
ppro
ach
,
pr
i
v
a
t
e
pr
ac
t
ice
s
ca
n
ha
rn
e
ss
AI
to
i
mprov
e
ca
r
e
efficie
n
c
y
a
n
d
p
a
t
ie
nt
s
a
t
i
s
fac
t
i
on
w
hi
l
e
a
vo
idi
n
g
p
i
t
fa
lls
.
C
on
c
lus
i
on
AI
i
nt
eg
r
a
t
i
on
i
n
pr
i
v
a
t
e
m
edica
l
pr
ac
t
ice
s
ha
s
mov
ed
f
rom
sp
ec
ul
a
t
i
on
to
r
ea
l
i
ty
.
E
x
ha
ust
i
v
e
r
ece
nt
surv
e
ys
a
n
d
ca
s
e
stu
die
s
s
h
ow
a
c
l
ea
r
tr
e
n
d
:
pr
ac
t
ice
s
a
r
e
ad
opt
i
n
g
AI
to
t
ack
l
e
t
hei
r
g
r
ea
t
e
st
headache
s
–
d
o
c
um
e
nt
a
t
i
on
,
c
ommun
ica
t
i
on
,
a
n
d
bi
ll
i
n
g
–
a
n
d
a
r
e
o
b
s
e
rv
i
n
g
t
a
n
gib
l
e
t
i
m
e
s
a
v
i
n
g
s
(
[3]
www
.
m
edica
l
ec
onom
ic
s
.
c
om
)
(
[36]
IntuitionLabs - Custom AI Software Development
from the leading AI expert Adrien Laurent AI in Private Practice: 2025 Adoption Trends & Statistics
© 2025 IntuitionLabs.ai - North America's Leading AI Software Development Firm for Pharmaceutical & Biotech. All rights reserved. Page 12 of 17
www
.
ic
t
hea
lt
h
.
or
g
).
A
lt
h
ou
gh
c
urr
e
nt
ad
opt
i
on
i
s
un
e
v
e
n
,
w
i
t
h
sm
a
ll
pr
ac
t
ice
s
l
aggi
n
g
behi
n
d
h
osp
i
t
a
l
syst
e
ms
(
[6]
www
.
h
n
a
-
n
e
t
.
c
om
)
(
[7]
www
.
a
m
a
-
a
ssn
.
or
g
),
t
he
ga
p
i
s
n
a
rrow
i
n
g
a
s
t
ech
nolo
g
y
m
a
tur
e
s
a
n
d
c
osts
fa
ll
.
D
o
c
tor
e
nt
h
us
ia
sm
i
s
high
,
w
i
t
h
m
a
ny
v
ie
w
i
n
g
AI
a
s
a
n
e
ss
e
nt
ia
l
tool
i
n
mo
de
rn
ca
r
e
(
[2]
www
.
a
m
a
-
a
ssn
.
or
g
)
(
[44]
www
.
a
m
a
-
a
ssn
.
or
g
),
a
n
d
a
n
e
m
e
r
gi
n
g
c
ons
e
nsus
t
ha
t
AI
w
i
ll
be
p
a
rt
o
f
st
a
n
da
r
d
pr
ac
t
ice
.
N
e
v
e
rt
he
l
e
ss
,
cha
ll
e
n
ge
s
r
e
m
ai
n
.
O
v
e
r
c
om
i
n
g
c
ost
,
da
t
a
,
a
n
d
trust
ba
rr
ie
rs
i
s
c
r
i
t
ica
l
.
B
ot
h
v
e
n
d
ors
a
n
d
r
eg
ul
a
tors
ha
v
e
a
rol
e
to
pl
a
y
i
n
prov
idi
n
g
v
a
l
ida
t
ed
,
i
nt
e
rop
e
r
ab
l
e
,
a
n
d
aff
or
dab
l
e
AI
solut
i
ons
su
i
t
ab
l
e
f
or
sm
a
ll
pr
ac
t
ice
s
.
P
ol
ic
ym
ake
rs
must
a
lso
e
nsur
e
e
qu
i
t
ab
l
e
acce
ss
so
t
ha
t
AI
-
d
r
i
v
e
n
qu
a
l
i
ty
i
mprov
e
m
e
nts
d
o
not
bec
om
e
t
he
e
x
c
lus
i
v
e
d
om
ai
n
o
f
w
e
ll
-
f
un
ded
syst
e
ms
.
T
he
i
mpl
ica
t
i
ons
f
or
hea
lt
hca
r
e
a
r
e
pro
f
oun
d
:
if
w
ide
ly
a
n
d
w
i
s
e
ly
de
ploy
ed
,
AI
ca
n
s
ig
n
ifica
ntly
r
ed
u
ce
c
l
i
n
icia
ns
ʼ
ad
m
i
n
i
str
a
t
i
v
e
lo
ad
,
i
mprov
e
p
a
t
ie
nt
e
n
gage
m
e
nt
,
a
n
d
e
v
e
n
s
a
v
e
l
i
v
e
s
b
y
e
n
ha
n
ci
n
g
diag
nost
ic
s
.
O
n
t
he
ot
he
r
ha
n
d
,
fai
lur
e
to
ad
opt
r
e
spons
ib
ly
c
oul
d
w
ide
n
di
sp
a
r
i
t
ie
s
a
n
d
y
ie
l
d
m
i
spl
aced
trust
i
n
unprov
e
n
tools
.
M
ov
i
n
g
f
orw
a
r
d
,
t
he
hea
lt
hca
r
e
c
ommun
i
ty
–
f
rom
pr
i
v
a
t
e
d
o
c
tors
to
n
a
t
i
on
a
l
l
eade
rs
–
must
c
ont
i
nu
e
to
s
ha
r
e
da
t
a
,
e
xp
e
r
ie
n
ce
s
,
a
n
d
be
st
pr
ac
t
ice
s
.
T
hi
s
w
i
ll
he
lp
e
nsur
e
t
ha
t
t
he
prom
i
s
e
o
f
AI
i
n
pr
i
v
a
t
e
pr
ac
t
ice
tr
a
nsl
a
t
e
s
i
nto
be
tt
e
r
out
c
om
e
s
f
or
p
a
t
ie
nts
a
n
d
a
mor
e
sust
ai
n
ab
l
e
pr
ac
t
ice
e
nv
i
ronm
e
nt
f
or
p
h
ys
icia
ns
.
R
efe
r
e
n
ce
s
:
A
ll
da
t
a
a
n
d
a
ss
e
rt
i
ons
ab
ov
e
a
r
e
d
r
a
wn
f
rom
p
ee
r
-
r
e
v
ie
w
ed
stu
die
s
,
i
n
d
ustry
surv
e
ys
,
a
n
d
e
xp
e
rt
a
n
a
lys
e
s
(
[1]
www
.
m
edica
l
ec
onom
ic
s
.
c
om
)
(
[2]
www
.
a
m
a
-
a
ssn
.
or
g
)
(
[7]
www
.
a
m
a
-
a
ssn
.
or
g
)
(
[36]
www
.
ic
t
hea
lt
h
.
or
g
)
(
[6]
www
.
h
n
a
-
n
e
t
.
c
om
)
(
[30]
www
.
a
m
a
-
a
ssn
.
or
g
)
(
[28]
acade
m
ic
.
oup
.
c
om
)
(
[14]
www
.
de
lo
i
tt
e
.
c
om
)
(
[13]
www
.
fie
r
cehea
lt
hca
r
e
.
c
om
)
(
[26]
n
e
wsroom
.
c
l
e
v
e
l
a
n
dc
l
i
n
ic
.
or
g
).
E
xt
e
rn
a
l
S
our
ce
s
[1]
h
ttps
://
www
.
m
edica
l
ec
onom
ic
s
.
c
om
/
v
ie
w
/
ai
-
ad
opt
i
on
-
acce
l
e
r
a
t
e
s
-
ac
ross
-
m
edica
l
-
pr
ac
t
ice
s
-
surv
e
y
-
s
h
ows
#
:~:
H
a
l
f
%
...
[2]
h
ttps
://
www
.
a
m
a
-
a
ssn
.
or
g
/
pr
e
ss
-
ce
nt
e
r
/
pr
e
ss
-
r
e
l
ea
s
e
s
/
a
m
a
-
p
h
ys
icia
n
-
e
nt
h
us
ia
sm
-
g
rows
-
hea
lt
h
-
ca
r
e
-
ai
#
:~:
%
2
A
%
2...
[3]
h
ttps
://
www
.
m
edica
l
ec
onom
ic
s
.
c
om
/
v
ie
w
/
ai
-
ad
opt
i
on
-
acce
l
e
r
a
t
e
s
-
ac
ross
-
m
edica
l
-
pr
ac
t
ice
s
-
surv
e
y
-
s
h
ows
#
:~:
S
uno
h
...
[4]
h
ttps
://
www
.
m
edica
l
ec
onom
ic
s
.
c
om
/
v
ie
w
/
ai
-
ad
opt
i
on
-
acce
l
e
r
a
t
e
s
-
ac
ross
-
m
edica
l
-
pr
ac
t
ice
s
-
surv
e
y
-
s
h
ows
#
:~:
F
a
x
%
2...
[5]
h
ttps
://
www
.
e
mp
a
t
hia
.
ai
/
b
lo
g
/
ai
-
i
n
-
pr
i
m
a
ry
-
ca
r
e
#
:~:
o
f
%
20...
[6]
h
ttps
://
www
.
h
n
a
-
n
e
t
.
c
om
/
ai
-
i
n
-
hea
lt
hca
r
e
/
pr
i
v
a
t
e
-
pr
ac
t
ice
s
-
face
-
ai
-
ad
opt
i
on
-
ga
p
#
:~:
T
ha
t
%
...
[7]
h
ttps
://
www
.
a
m
a
-
a
ssn
.
or
g
/
pr
ac
t
ice
-
m
a
n
age
m
e
nt
/
digi
t
a
l
-
hea
lt
h
/
r
ead
y
-
hea
lt
h
-
ai
-
i
t
-
m
a
y
-
de
p
e
n
d
-
your
-
pr
ac
t
ice
-
s
e
tt
i
n
g
#
:~:
U
s
e
%
2...
[8]
h
ttps
://
www
.
a
m
a
-
a
ssn
.
or
g
/
pr
ac
t
ice
-
m
a
n
age
m
e
nt
/
digi
t
a
l
-
hea
lt
h
/
r
ead
y
-
hea
lt
h
-
ai
-
i
t
-
m
a
y
-
de
p
e
n
d
-
your
-
pr
ac
t
ice
-
s
e
tt
i
n
g
#
:~:
%
E
2
%
8...
[9]
h
ttps
://
www
.
h
n
a
-
n
e
t
.
c
om
/
ai
-
i
n
-
hea
lt
hca
r
e
/
pr
i
v
a
t
e
-
pr
ac
t
ice
s
-
face
-
ai
-
ad
opt
i
on
-
ga
p
#
:~:,
%
E
2
%
...
[10]
h
ttps
://
www
.
a
m
a
-
a
ssn
.
or
g
/
pr
e
ss
-
ce
nt
e
r
/
pr
e
ss
-
r
e
l
ea
s
e
s
/
a
m
a
-
p
h
ys
icia
n
-
e
nt
h
us
ia
sm
-
g
rows
-
hea
lt
h
-
ca
r
e
-
ai
#
:~:
tr
ea
t
...
[11]
h
ttps
://
www
.
h
n
a
-
n
e
t
.
c
om
/
ai
-
i
n
-
hea
lt
hca
r
e
/
pr
i
v
a
t
e
-
pr
ac
t
ice
s
-
face
-
ai
-
ad
opt
i
on
-
ga
p
#
:~:
T
he
%
2...
[12]
h
ttps
://
www
.
ic
t
hea
lt
h
.
or
g
/
n
e
ws
/
f
utur
e
-
hea
lt
h
-
i
n
de
x
-2025-
d
o
c
tors
-
trust
-
i
n
-
t
he
-
pow
e
r
-
o
f
-
ai
#
:~:
A
s
%
20...
[13]
h
ttps
://
www
.
fie
r
cehea
lt
hca
r
e
.
c
om
/
hea
lt
h
-
t
ech
/
a
t
he
n
ahea
lt
h
-
unv
ei
ls
-
ai
-
up
g
r
ade
s
-
eh
r
-
e
n
ha
n
ce
-
c
l
i
n
ica
l
-
summ
a
r
ie
s
-
i
nt
e
rop
e
r
abi
l
i
ty
-
a
n
d
#
:~:
A
t
he
n
...
IntuitionLabs - Custom AI Software Development
from the leading AI expert Adrien Laurent AI in Private Practice: 2025 Adoption Trends & Statistics
© 2025 IntuitionLabs.ai - North America's Leading AI Software Development Firm for Pharmaceutical & Biotech. All rights reserved. Page 13 of 17
[14]
h
ttps
://
www
.
de
lo
i
tt
e
.
c
om
/
us
/
e
n
/
I
n
d
ustr
ie
s
/
l
ife
-
s
cie
n
ce
s
-
hea
lt
h
-
ca
r
e
/
a
rt
ic
l
e
s
/
ge
n
e
r
a
t
i
v
e
-
ai
-
i
n
-
hea
lt
hca
r
e
.
h
tml
#
:~:
%
2
A
%
2...
[15]
h
ttps
://
www
.
h
n
a
-
n
e
t
.
c
om
/
ai
-
i
n
-
hea
lt
hca
r
e
/
pr
i
v
a
t
e
-
pr
ac
t
ice
s
-
face
-
ai
-
ad
opt
i
on
-
ga
p
#
:~:,
ca
r
e
...
[16]
h
ttps
://
www
.
m
edica
l
ec
onom
ic
s
.
c
om
/
v
ie
w
/
a
m
a
-
p
a
n
e
l
-
ca
lls
-
f
or
-
tr
a
nsp
a
r
e
n
c
y
-
fede
r
a
l
-
ov
e
rs
igh
t
-
to
-
add
r
e
ss
-
r
a
p
id
-
ai
-
e
xp
a
ns
i
on
#
:~:
K
e
y
%
2...
[17]
h
ttps
://
www
.
m
g
m
a
.
c
om
/
m
g
m
a
-
st
a
t
/
p
ace
-
o
f
-
ai
-
ad
opt
i
on
-
i
n
-
m
edica
l
-
g
roups
-
qu
icke
ns
-
i
n
-2024
#
:~:
A
n
%
20...
[18]
h
ttps
://
www
.
m
edica
l
ec
onom
ic
s
.
c
om
/
v
ie
w
/
ai
-
ad
opt
i
on
-
sur
ge
s
-
ac
ross
-
t
he
-
hea
lt
h
-
ca
r
e
-
i
n
d
ustry
#
:~:
A
cc
or
...
[19]
h
ttps
://
www
.
ic
t
hea
lt
h
.
or
g
/
n
e
ws
/
f
utur
e
-
hea
lt
h
-
i
n
de
x
-2025-
d
o
c
tors
-
trust
-
i
n
-
t
he
-
pow
e
r
-
o
f
-
ai
#
:~:
H
ow
%
2...
[20]
h
ttps
://
www
.
ic
t
hea
lt
h
.
or
g
/
n
e
ws
/
f
utur
e
-
hea
lt
h
-
i
n
de
x
-2025-
d
o
c
tors
-
trust
-
i
n
-
t
he
-
pow
e
r
-
o
f
-
ai
#
:~:
D
o
c
to
...
[21]
h
ttps
://
pm
c
.
n
cbi
.
nlm
.
n
ih
.
g
ov
/
a
rt
ic
l
e
s
/
PMC
12647557/
#
:~:25,
t
h
...
[22]
h
ttps
://
i
ntu
i
t
i
onl
ab
s
.
ai
/
a
rt
ic
l
e
s
/
ai
-
ad
opt
i
on
-
us
-
h
osp
i
t
a
ls
-2025
#
:~:
E
mp
i
r
...
[23]
h
ttps
://
n
e
wsroom
.
c
l
e
v
e
l
a
n
dc
l
i
n
ic
.
or
g
/2025/09/23/
c
l
e
v
e
l
a
n
d
-
c
l
i
n
ic
-
a
nnoun
ce
s
-
t
he
-
e
xp
a
n
ded
-
rollout
-
o
f
-
ba
y
e
s
ia
n
-
hea
lt
h
s
-
ai
-
pl
a
t
f
orm
-
f
or
-
s
e
ps
i
s
-
de
t
ec
t
i
on
#
:~:
C
ont
e
...
[24]
h
ttps
://
www
.
e
mp
a
t
hia
.
ai
/
b
lo
g
/
ai
-
i
n
-
pr
i
m
a
ry
-
ca
r
e
#
:~:
P
r
i
m
a
...
[25]
h
ttps
://
www
.
a
m
a
-
a
ssn
.
or
g
/
pr
e
ss
-
ce
nt
e
r
/
pr
e
ss
-
r
e
l
ea
s
e
s
/
a
m
a
-
p
h
ys
icia
n
-
e
nt
h
us
ia
sm
-
g
rows
-
hea
lt
h
-
ca
r
e
-
ai
#
:~:
%
E
2
%
8...
[26]
h
ttps
://
n
e
wsroom
.
c
l
e
v
e
l
a
n
dc
l
i
n
ic
.
or
g
/2025/09/23/
c
l
e
v
e
l
a
n
d
-
c
l
i
n
ic
-
a
nnoun
ce
s
-
t
he
-
e
xp
a
n
ded
-
rollout
-
o
f
-
ba
y
e
s
ia
n
-
hea
lt
h
s
-
ai
-
pl
a
t
f
orm
-
f
or
-
s
e
ps
i
s
-
de
t
ec
t
i
on
#
:~:
p
e
r
f
o
...
[27]
h
ttps
://
acade
m
ic
.
oup
.
c
om
/
ja
m
ia
/
ad
v
a
n
ce
-
a
rt
ic
l
e
/
d
o
i
/10.1093/
ja
m
ia
/
o
caf
065/8125015?
s
ea
r
ch
r
e
sult
=1
#
:~:
A
mon
g
...
[28]
h
ttps
://
acade
m
ic
.
oup
.
c
om
/
ja
m
ia
/
ad
v
a
n
ce
-
a
rt
ic
l
e
/
d
o
i
/10.1093/
ja
m
ia
/
o
caf
065/8125015?
s
ea
r
ch
r
e
sult
=1
#
:~:
e
x
ce
p
...
[29]
h
ttps
://
pm
c
.
n
cbi
.
nlm
.
n
ih
.
g
ov
/
a
rt
ic
l
e
s
/
PMC
12254672/
#
:~:
bei
n
g
...
[30]
h
ttps
://
www
.
a
m
a
-
a
ssn
.
or
g
/
pr
ac
t
ice
-
m
a
n
age
m
e
nt
/
digi
t
a
l
-
hea
lt
h
/
r
ead
y
-
hea
lt
h
-
ai
-
i
t
-
m
a
y
-
de
p
e
n
d
-
your
-
pr
ac
t
ice
-
s
e
tt
i
n
g
#
:~:
D
o
c
um
...
[31]
h
ttps
://
www
.
m
g
m
a
.
c
om
/
m
g
m
a
-
st
a
t
/
p
ace
-
o
f
-
ai
-
ad
opt
i
on
-
i
n
-
m
edica
l
-
g
roups
-
qu
icke
ns
-
i
n
-2024
#
:~:,
c
l
ai
...
[32]
h
ttps
://
www
.
a
m
a
-
a
ssn
.
or
g
/
pr
ac
t
ice
-
m
a
n
age
m
e
nt
/
digi
t
a
l
-
hea
lt
h
/
r
ead
y
-
hea
lt
h
-
ai
-
i
t
-
m
a
y
-
de
p
e
n
d
-
your
-
pr
ac
t
ice
-
s
e
tt
i
n
g
#
:~:
T
he
%
2...
[33]
h
ttps
://
www
.
s
i
m
b
o
.
ai
/
b
lo
g
/
t
he
-
rol
e
-
o
f
-
ai
-
cha
t
b
ots
-
i
n
-
r
e
volut
i
on
i
z
i
n
g
-
a
ppo
i
ntm
e
nt
-
s
ched
ul
i
n
g
-
a
n
d
-
a
utom
a
t
ed
-
r
e
s
che
d
ul
i
n
g
-
to
-
e
n
ha
n
ce
-
p
a
t
ie
nt
-
c
onv
e
n
ie
n
ce
-
a
n
d
-
r
ed
u
ce
-
ad
m
i
n
i
str
a
t
i
v
e
-
b
ur
de
n
-2858961/
#
:~:
F
or
%
2...
[34]
h
ttps
://
www
.
a
m
a
-
a
ssn
.
or
g
/
pr
ac
t
ice
-
m
a
n
age
m
e
nt
/
digi
t
a
l
-
hea
lt
h
/
r
ead
y
-
hea
lt
h
-
ai
-
i
t
-
m
a
y
-
de
p
e
n
d
-
your
-
pr
ac
t
ice
-
s
e
tt
i
n
g
#
:~:
G
e
n
e
r
...
[35]
h
ttps
://
www
.
m
g
m
a
.
c
om
/
m
g
m
a
-
st
a
t
/
p
ace
-
o
f
-
ai
-
ad
opt
i
on
-
i
n
-
m
edica
l
-
g
roups
-
qu
icke
ns
-
i
n
-2024
#
:~:,
f
or
%
...
[36]
h
ttps
://
www
.
ic
t
hea
lt
h
.
or
g
/
n
e
ws
/
f
utur
e
-
hea
lt
h
-
i
n
de
x
-2025-
d
o
c
tors
-
trust
-
i
n
-
t
he
-
pow
e
r
-
o
f
-
ai
#
:~:
M
ea
nw
...
[37]
h
ttps
://
www
.
m
akeb
ot
.
ai
/
b
lo
g
-
e
n
/
de
lo
i
tt
e
-75-
o
f
-
hea
lt
hca
r
e
-
l
eade
rs
-
a
r
e
-
s
ca
l
i
n
g
-
ge
n
e
r
a
t
i
v
e
-
ai
-
to
-
tr
a
ns
f
orm
-
ca
r
e
-
a
n
d
-
o
p
e
r
a
t
i
ons
#
:~:
%
2
A
%
2...
[38]
h
ttps
://
www
.
hea
lt
hi
t
.
g
ov
/
da
t
a
/
da
t
a
-
b
r
ief
s
/
h
osp
i
t
a
l
-
tr
e
n
d
s
-
us
e
-
e
v
a
lu
a
t
i
on
-
a
n
d
-
g
ov
e
rn
a
n
ce
-
pr
edic
t
i
v
e
-
ai
-2023-2024
#
:
~:
U
r
ba
n
...
[39]
h
ttps
://
www
.
a
m
a
-
a
ssn
.
or
g
/
pr
e
ss
-
ce
nt
e
r
/
pr
e
ss
-
r
e
l
ea
s
e
s
/
a
m
a
-
p
h
ys
icia
n
-
e
nt
h
us
ia
sm
-
g
rows
-
hea
lt
h
-
ca
r
e
-
ai
#
:~:,86...
[40]
h
ttps
://
www
.
a
m
a
-
a
ssn
.
or
g
/
pr
e
ss
-
ce
nt
e
r
/
pr
e
ss
-
r
e
l
ea
s
e
s
/
a
m
a
-
p
h
ys
icia
n
-
e
nt
h
us
ia
sm
-
g
rows
-
hea
lt
h
-
ca
r
e
-
ai
#
:~:
T
he
%
2...
[41]
h
ttps
://
www
.
h
n
a
-
n
e
t
.
c
om
/
ai
-
i
n
-
hea
lt
hca
r
e
/
pr
i
v
a
t
e
-
pr
ac
t
ice
s
-
face
-
ai
-
ad
opt
i
on
-
ga
p
#
:~:
E
v
e
n
%
...
IntuitionLabs - Custom AI Software Development
from the leading AI expert Adrien Laurent AI in Private Practice: 2025 Adoption Trends & Statistics
© 2025 IntuitionLabs.ai - North America's Leading AI Software Development Firm for Pharmaceutical & Biotech. All rights reserved. Page 14 of 17
[42]
h
ttps
://
www
.
h
n
a
-
n
e
t
.
c
om
/
ai
-
i
n
-
hea
lt
hca
r
e
/
pr
i
v
a
t
e
-
pr
ac
t
ice
s
-
face
-
ai
-
ad
opt
i
on
-
ga
p
#
:~:
S
t
e
ps
...
[43]
h
ttps
://
c
lou
dga
t
e
.
hea
lt
hca
r
ei
tn
e
ws
.
c
om
/
n
e
ws
/
h
ow
-
os
f
-
hea
lt
hca
r
e
-
gai
n
ed
-26
m
-
t
h
rou
gh
-
i
ts
-
c
l
i
n
ica
l
-
ai
-
pl
a
t
f
orm
#
:~:
W
h
e
n
%
...
[44]
h
ttps
://
www
.
a
m
a
-
a
ssn
.
or
g
/
pr
ac
t
ice
-
m
a
n
age
m
e
nt
/
digi
t
a
l
-
hea
lt
h
/
r
ead
y
-
hea
lt
h
-
ai
-
i
t
-
m
a
y
-
de
p
e
n
d
-
your
-
pr
ac
t
ice
-
s
e
tt
i
n
g
#
:~:
I
n
%
20...
[45]
h
ttps
://
www
.
fie
r
cehea
lt
hca
r
e
.
c
om
/
hea
lt
h
-
t
ech
/
a
t
he
n
ahea
lt
h
-
unv
ei
ls
-
ai
-
up
g
r
ade
s
-
eh
r
-
e
n
ha
n
ce
-
c
l
i
n
ica
l
-
summ
a
r
ie
s
-
i
nt
e
rop
e
r
abi
l
i
ty
-
a
n
d
#
:~:
N
e
w
%
2...
[46]
h
ttps
://
www
.
a
m
a
-
a
ssn
.
or
g
/
pr
ac
t
ice
-
m
a
n
age
m
e
nt
/
digi
t
a
l
-
hea
lt
h
/
r
ead
y
-
hea
lt
h
-
ai
-
i
t
-
m
a
y
-
de
p
e
n
d
-
your
-
pr
ac
t
ice
-
s
e
tt
i
n
g
#
:~:
%
E
2
%
8...
[47]
h
ttps
://
www
.
a
m
a
-
a
ssn
.
or
g
/
pr
ac
t
ice
-
m
a
n
age
m
e
nt
/
digi
t
a
l
-
hea
lt
h
/
r
ead
y
-
hea
lt
h
-
ai
-
i
t
-
m
a
y
-
de
p
e
n
d
-
your
-
pr
ac
t
ice
-
s
e
tt
i
n
g
#
:~:
%
E
2
%
8...
[48]
h
ttps
://
www
.
a
m
a
-
a
ssn
.
or
g
/
pr
ac
t
ice
-
m
a
n
age
m
e
nt
/
digi
t
a
l
-
hea
lt
h
/
r
ead
y
-
hea
lt
h
-
ai
-
i
t
-
m
a
y
-
de
p
e
n
d
-
your
-
pr
ac
t
ice
-
s
e
tt
i
n
g
#
:~:
H
e
r
%
2...
[49]
h
ttps
://
www
.
fie
r
cehea
lt
hca
r
e
.
c
om
/
hea
lt
h
-
t
ech
/
a
t
he
n
ahea
lt
h
-
unv
ei
ls
-
ai
-
up
g
r
ade
s
-
eh
r
-
e
n
ha
n
ce
-
c
l
i
n
ica
l
-
summ
a
r
ie
s
-
i
nt
e
rop
e
r
abi
l
i
ty
-
a
n
d
#
:~:
A
t
he
n
...
[50]
h
ttps
://
www
.
ic
t
hea
lt
h
.
or
g
/
n
e
ws
/
f
utur
e
-
hea
lt
h
-
i
n
de
x
-2025-
d
o
c
tors
-
trust
-
i
n
-
t
he
-
pow
e
r
-
o
f
-
ai
#
:~:
a
n
a
ly
...
[51]
h
ttps
://
www
.
a
m
a
-
a
ssn
.
or
g
/
pr
ac
t
ice
-
m
a
n
age
m
e
nt
/
digi
t
a
l
-
hea
lt
h
/
r
ead
y
-
hea
lt
h
-
ai
-
i
t
-
m
a
y
-
de
p
e
n
d
-
your
-
pr
ac
t
ice
-
s
e
tt
i
n
g
#
:~:
T
he
%
2...
IntuitionLabs - Custom AI Software Development
from the leading AI expert Adrien Laurent AI in Private Practice: 2025 Adoption Trends & Statistics
© 2025 IntuitionLabs.ai - North America's Leading AI Software Development Firm for Pharmaceutical & Biotech. All rights reserved. Page 15 of 17
I
ntu
i
t
i
on
L
ab
s
-
I
n
d
ustry
L
eade
rs
hi
p
&
S
e
rv
ice
s
N
ort
h
A
m
e
r
ica
'
s
#
1
AI S
o
f
tw
a
r
e
D
e
v
e
lopm
e
nt
F
i
rm
f
or
P
ha
rm
ace
ut
ica
l
&
B
i
ot
ech
:
I
ntu
i
t
i
on
L
ab
s
l
ead
s
t
he
U
S
m
a
r
ke
t
i
n
c
ustom
AI
so
f
tw
a
r
e
de
v
e
lopm
e
nt
a
n
d
p
ha
rm
a
i
mpl
e
m
e
nt
a
t
i
ons
w
i
t
h
prov
e
n
r
e
sults
ac
ross
pu
b
l
ic
bi
ot
ech
a
n
d
p
ha
rm
ace
ut
ica
l
c
omp
a
n
ie
s
.
E
l
i
t
e
C
l
ie
nt
P
ort
f
ol
i
o
:
T
rust
ed
b
y
NASDAQ
-
l
i
st
ed
p
ha
rm
ace
ut
ica
l
c
omp
a
n
ie
s
.
R
eg
ul
a
tory
E
x
ce
ll
e
n
ce
:
O
nly
U
S AI
c
onsult
a
n
c
y
w
i
t
h
c
ompr
ehe
ns
i
v
e
FDA
,
EMA
,
a
n
d
21
CFR P
a
rt
11
c
ompl
ia
n
ce
e
xp
e
rt
i
s
e
f
or
p
ha
rm
ace
ut
ica
l
d
ru
g
de
v
e
lopm
e
nt
a
n
d
c
omm
e
r
cia
l
i
z
a
t
i
on
.
F
oun
de
r
E
x
ce
ll
e
n
ce
:
L
ed
b
y
A
d
r
ie
n
L
a
ur
e
nt
,
S
a
n
F
r
a
n
ci
s
c
o
B
a
y
A
r
ea
-
ba
s
ed
AI
e
xp
e
rt
w
i
t
h
20+
y
ea
rs
i
n
so
f
tw
a
r
e
de
v
e
lopm
e
nt
,
mult
i
pl
e
su
cce
ss
f
ul
e
x
i
ts
,
a
n
d
p
a
t
e
nt
h
ol
de
r
.
R
ec
o
g
n
i
z
ed
a
s
on
e
o
f
t
he
top
AI
e
xp
e
rts
i
n
t
he
U
SA
.
C
ustom
AI S
o
f
tw
a
r
e
D
e
v
e
lopm
e
nt
:
B
u
i
l
d
t
ai
lor
ed
p
ha
rm
ace
ut
ica
l
AI
a
ppl
ica
t
i
ons
,
c
ustom
CRM
s
,
cha
t
b
ots
,
a
n
d
ERP
syst
e
ms
w
i
t
h
ad
v
a
n
ced
a
n
a
lyt
ic
s
a
n
d
r
eg
ul
a
tory
c
ompl
ia
n
ce
ca
p
abi
l
i
t
ie
s
.
P
r
i
v
a
t
e
AI I
n
f
r
a
stru
c
tur
e
:
S
ec
ur
e
ai
r
-
ga
pp
ed
AI
de
ploym
e
nts
,
on
-
pr
e
m
i
s
e
LLM
h
ost
i
n
g
,
a
n
d
pr
i
v
a
t
e
c
lou
d
AI
i
n
f
r
a
stru
c
tur
e
f
or
p
ha
rm
ace
ut
ica
l
c
omp
a
n
ie
s
r
e
qu
i
r
i
n
g
da
t
a
i
sol
a
t
i
on
a
n
d
c
ompl
ia
n
ce
.
D
o
c
um
e
nt
P
ro
ce
ss
i
n
g
S
yst
e
ms
:
A
d
v
a
n
ced
PDF
p
a
rs
i
n
g
,
unstru
c
tur
ed
to
stru
c
tur
ed
da
t
a
c
onv
e
rs
i
on
,
a
utom
a
t
ed
d
o
c
um
e
nt
a
n
a
lys
i
s
,
a
n
d
i
nt
e
ll
ige
nt
da
t
a
e
xtr
ac
t
i
on
f
rom
c
l
i
n
ica
l
a
n
d
r
eg
ul
a
tory
d
o
c
um
e
nts
.
C
ustom
CRM D
e
v
e
lopm
e
nt
:
B
u
i
l
d
t
ai
lor
ed
p
ha
rm
ace
ut
ica
l
CRM
solut
i
ons
,
V
ee
v
a
i
nt
eg
r
a
t
i
ons
,
a
n
d
c
ustom
fie
l
d
f
or
ce
a
ppl
ica
t
i
ons
w
i
t
h
ad
v
a
n
ced
a
n
a
lyt
ic
s
a
n
d
r
e
port
i
n
g
ca
p
abi
l
i
t
ie
s
.
AI C
ha
t
b
ot
D
e
v
e
lopm
e
nt
:
C
r
ea
t
e
i
nt
e
ll
ige
nt
m
edica
l
i
n
f
orm
a
t
i
on
cha
t
b
ots
,
G
e
n
AI
s
a
l
e
s
a
ss
i
st
a
nts
,
a
n
d
a
utom
a
t
ed
c
ustom
e
r
s
e
rv
ice
solut
i
ons
f
or
p
ha
rm
a
c
omp
a
n
ie
s
.
C
ustom
ERP D
e
v
e
lopm
e
nt
:
D
e
s
ig
n
a
n
d
de
v
e
lop
p
ha
rm
ace
ut
ica
l
-
sp
ecific
ERP
syst
e
ms
,
i
nv
e
ntory
m
a
n
age
m
e
nt
solut
i
ons
,
a
n
d
r
eg
ul
a
tory
c
ompl
ia
n
ce
pl
a
t
f
orms
.
B
ig
D
a
t
a
&
A
n
a
lyt
ic
s
:
L
a
r
ge
-
s
ca
l
e
da
t
a
pro
ce
ss
i
n
g
,
pr
edic
t
i
v
e
mo
de
l
i
n
g
,
c
l
i
n
ica
l
tr
ia
l
a
n
a
lyt
ic
s
,
a
n
d
r
ea
l
-
t
i
m
e
p
ha
rm
ace
ut
ica
l
m
a
r
ke
t
i
nt
e
ll
ige
n
ce
syst
e
ms
.
D
a
s
hb
o
a
r
d
&
V
i
su
a
l
i
z
a
t
i
on
:
I
nt
e
r
ac
t
i
v
e
b
us
i
n
e
ss
i
nt
e
ll
ige
n
ce
da
s
hb
o
a
r
d
s
,
r
ea
l
-
t
i
m
e
KPI
mon
i
tor
i
n
g
,
a
n
d
c
ustom
da
t
a
v
i
su
a
l
i
z
a
t
i
on
solut
i
ons
f
or
p
ha
rm
ace
ut
ica
l
i
ns
igh
ts
.
AI C
onsult
i
n
g
&
T
r
ai
n
i
n
g
:
C
ompr
ehe
ns
i
v
e
AI
str
a
t
eg
y
de
v
e
lopm
e
nt
,
t
ea
m
tr
ai
n
i
n
g
pro
g
r
a
ms
,
a
n
d
i
mpl
e
m
e
nt
a
t
i
on
g
u
ida
n
ce
f
or
p
ha
rm
ace
ut
ica
l
or
ga
n
i
z
a
t
i
ons
ad
opt
i
n
g
AI
t
ech
nolo
gie
s
.
C
ont
ac
t
f
oun
de
r
A
d
r
ie
n
L
a
ur
e
nt
a
n
d
t
ea
m
a
t
h
ttps
://
i
ntu
i
t
i
onl
ab
s
.
ai
/
c
ont
ac
t
f
or
a
c
onsult
a
t
i
on
.
IntuitionLabs - Custom AI Software Development
from the leading AI expert Adrien Laurent AI in Private Practice: 2025 Adoption Trends & Statistics
© 2025 IntuitionLabs.ai - North America's Leading AI Software Development Firm for Pharmaceutical & Biotech. All rights reserved. Page 16 of 17
DISCLAIMER
T
he
i
n
f
orm
a
t
i
on
c
ont
ai
n
ed
i
n
t
hi
s
d
o
c
um
e
nt
i
s
prov
ided
f
or
ed
u
ca
t
i
on
a
l
a
n
d
i
n
f
orm
a
t
i
on
a
l
purpos
e
s
only
.
W
e
m
ake
no
r
e
pr
e
s
e
nt
a
t
i
ons
or
w
a
rr
a
nt
ie
s
o
f
a
ny
ki
n
d
,
e
xpr
e
ss
or
i
mpl
ied
,
ab
out
t
he
c
ompl
e
t
e
n
e
ss
,
acc
ur
ac
y
,
r
e
l
iabi
l
i
ty
,
su
i
t
abi
l
i
ty
,
or
a
v
ai
l
abi
l
i
ty
o
f
t
he
i
n
f
orm
a
t
i
on
c
ont
ai
n
ed
he
r
ei
n
.
A
ny
r
e
l
ia
n
ce
you
pl
ace
on
su
ch
i
n
f
orm
a
t
i
on
i
s
str
ic
tly
a
t
your
own
r
i
s
k
.
I
n
no
e
v
e
nt
w
i
ll
I
ntu
i
t
i
on
L
ab
s
.
ai
or
i
ts
r
e
pr
e
s
e
nt
a
t
i
v
e
s
be
l
iab
l
e
f
or
a
ny
loss
or
da
m
age
i
n
c
lu
di
n
g
w
i
t
h
out
l
i
m
i
t
a
t
i
on
,
i
n
di
r
ec
t
or
c
ons
e
qu
e
nt
ia
l
loss
or
da
m
age
,
or
a
ny
loss
or
da
m
age
w
ha
tso
e
v
e
r
a
r
i
s
i
n
g
f
rom
t
he
us
e
o
f
i
n
f
orm
a
t
i
on
pr
e
s
e
nt
ed
i
n
t
hi
s
d
o
c
um
e
nt
.
T
hi
s
d
o
c
um
e
nt
m
a
y
c
ont
ai
n
c
ont
e
nt
ge
n
e
r
a
t
ed
w
i
t
h
t
he
a
ss
i
st
a
n
ce
o
f
a
rt
ificia
l
i
nt
e
ll
ige
n
ce
t
ech
nolo
gie
s
.
AI
-
ge
n
e
r
a
t
ed
c
ont
e
nt
m
a
y
c
ont
ai
n
e
rrors
,
om
i
ss
i
ons
,
or
i
n
acc
ur
acie
s
.
R
eade
rs
a
r
e
ad
v
i
s
ed
to
i
n
de
p
e
n
de
ntly
v
e
r
if
y
a
ny
c
r
i
t
ica
l
i
n
f
orm
a
t
i
on
bef
or
e
ac
t
i
n
g
upon
i
t
.
A
ll
pro
d
u
c
t
n
a
m
e
s
,
lo
g
os
,
b
r
a
n
d
s
,
tr
ade
m
a
r
k
s
,
a
n
d
r
egi
st
e
r
ed
tr
ade
m
a
r
k
s
m
e
nt
i
on
ed
i
n
t
hi
s
d
o
c
um
e
nt
a
r
e
t
he
prop
e
rty
o
f
t
hei
r
r
e
sp
ec
t
i
v
e
own
e
rs
.
A
ll
c
omp
a
ny
,
pro
d
u
c
t
,
a
n
d
s
e
rv
ice
n
a
m
e
s
us
ed
i
n
t
hi
s
d
o
c
um
e
nt
a
r
e
f
or
ide
nt
ifica
t
i
on
purpos
e
s
only
.
U
s
e
o
f
t
he
s
e
n
a
m
e
s
,
lo
g
os
,
tr
ade
m
a
r
k
s
,
a
n
d
b
r
a
n
d
s
d
o
e
s
not
i
mply
e
n
d
ors
e
m
e
nt
b
y
t
he
r
e
sp
ec
t
i
v
e
tr
ade
m
a
r
k
h
ol
de
rs
.
I
ntu
i
t
i
on
L
ab
s
.
ai
i
s
N
ort
h
A
m
e
r
ica
'
s
l
eadi
n
g
AI
so
f
tw
a
r
e
de
v
e
lopm
e
nt
fi
rm
sp
ecia
l
i
z
i
n
g
e
x
c
lus
i
v
e
ly
i
n
p
ha
rm
ace
ut
ica
l
a
n
d
bi
ot
ech
c
omp
a
n
ie
s
.
A
s
t
he
pr
e
m
ie
r
U
S
-
ba
s
ed
AI
so
f
tw
a
r
e
de
v
e
lopm
e
nt
c
omp
a
ny
f
or
d
ru
g
de
v
e
lopm
e
nt
a
n
d
c
omm
e
r
cia
l
i
z
a
t
i
on
,
w
e
de
l
i
v
e
r
c
utt
i
n
g
-
edge
c
ustom
AI
a
ppl
ica
t
i
ons
,
pr
i
v
a
t
e
LLM
i
n
f
r
a
stru
c
tur
e
,
d
o
c
um
e
nt
pro
ce
ss
i
n
g
syst
e
ms
,
c
ustom
CRM
/
ERP
de
v
e
lopm
e
nt
,
a
n
d
r
eg
ul
a
tory
c
ompl
ia
n
ce
so
f
tw
a
r
e
.
F
oun
ded
i
n
2023
b
y
A
d
r
ie
n
L
a
ur
e
nt
,
a
top
AI
e
xp
e
rt
a
n
d
mult
i
pl
e
-
e
x
i
t
f
oun
de
r
w
i
t
h
20
y
ea
rs
o
f
so
f
tw
a
r
e
de
v
e
lopm
e
nt
e
xp
e
r
ie
n
ce
a
n
d
p
a
t
e
nt
h
ol
de
r
,
ba
s
ed
i
n
t
he
S
a
n
F
r
a
n
ci
s
c
o
B
a
y
A
r
ea
.
T
hi
s
d
o
c
um
e
nt
d
o
e
s
not
c
onst
i
tut
e
pro
fe
ss
i
on
a
l
or
l
ega
l
ad
v
ice
.
F
or
sp
ecific
g
u
ida
n
ce
r
e
l
a
t
ed
to
your
b
us
i
n
e
ss
n
eed
s
,
pl
ea
s
e
c
onsult
w
i
t
h
a
ppropr
ia
t
e
qu
a
l
ified
pro
fe
ss
i
on
a
ls
.
©
2025
I
ntu
i
t
i
on
L
ab
s
.
ai
.
A
ll
r
igh
ts
r
e
s
e
rv
ed
.
IntuitionLabs - Custom AI Software Development
from the leading AI expert Adrien Laurent AI in Private Practice: 2025 Adoption Trends & Statistics
© 2025 IntuitionLabs.ai - North America's Leading AI Software Development Firm for Pharmaceutical & Biotech. All rights reserved. Page 17 of 17
